Yoshihiro Kawaoka
#17,227
Most Influential Person Now
Japanese microbiology researcher
Yoshihiro Kawaoka's AcademicInfluence.com Rankings
Yoshihiro Kawaokabiology Degrees
Biology
#811
World Rank
#1403
Historical Rank
Virology
#15
World Rank
#16
Historical Rank
Microbiology
#44
World Rank
#60
Historical Rank
Download Badge
Biology
Yoshihiro Kawaoka's Degrees
- PhD Veterinary Medicine Hokkaido University
Why Is Yoshihiro Kawaoka Influential?
(Suggest an Edit or Addition)According to Wikipedia, Yoshihiro Kawaoka is a virologist specializing in the study of the influenza and Ebola viruses. He holds a professorship in virology in the Department of Pathobiological Sciences at the University of Wisconsin-Madison, USA, and at the University of Tokyo, Japan.
Yoshihiro Kawaoka's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Emergence and pandemic potential of swine-origin H1N1 influenza virus (2009) (1513)
- A DNA transfection system for generation of influenza A virus from eight plasmids. (2000) (1459)
- Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses (2001) (1325)
- Avian flu: Influenza virus receptors in the human airway (2006) (1315)
- Generation of influenza A viruses entirely from cloned cDNAs. (1999) (1245)
- In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses (2009) (1067)
- Molecular Basis for the Generation in Pigs of Influenza A Viruses with Pandemic Potential (1998) (1038)
- Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus (2007) (939)
- Early Alterations of the Receptor-Binding Properties of H1, H2, and H3 Avian Influenza Virus Hemagglutinins after Their Introduction into Mammals (2000) (838)
- Experimental adaptation of an influenza H5 haemagglutinin (HA) confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets (2012) (828)
- Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. (1994) (812)
- Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics (1989) (809)
- Resistant influenza A viruses in children treated with oseltamivir: descriptive study (2004) (806)
- Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development (2020) (773)
- Avian flu: Isolation of drug-resistant H5N1 virus (2005) (734)
- Influenza: lessons from past pandemics, warnings from current incidents (2005) (716)
- SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo (2020) (681)
- Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift (2021) (670)
- The Surface Glycoproteins of H5 Influenza Viruses Isolated from Humans, Chickens, and Wild Aquatic Birds Have Distinguishable Properties (1999) (637)
- Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors (2006) (617)
- Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. (1998) (605)
- A system for functional analysis of Ebola virus glycoprotein. (1997) (581)
- Pandemic Threat Posed by Avian Influenza A Viruses (2001) (566)
- Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice (2000) (543)
- Sialic Acid Species as a Determinant of the Host Range of Influenza A Viruses (2000) (496)
- Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus (2004) (492)
- Single-Reaction Genomic Amplification Accelerates Sequencing and Vaccine Production for Classical and Swine Origin Human Influenza A Viruses (2009) (474)
- Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations (2010) (433)
- Drosophila RNAi screen identifies host genes important for influenza virus replication (2008) (427)
- Architecture of ribonucleoprotein complexes in influenza A virus particles (2006) (415)
- Potential for transmission of avian influenza viruses to pigs. (1994) (411)
- PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice. (2004) (411)
- Genetic reassortment between avian and human influenza A viruses in Italian pigs. (1993) (400)
- A Single-Amino-Acid Substitution in the NS1 Protein Changes the Pathogenicity of H5N1 Avian Influenza Viruses in Mice (2007) (397)
- The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza (2013) (395)
- Balanced Hemagglutinin and Neuraminidase Activities Are Critical for Efficient Replication of Influenza A Virus (2000) (394)
- Ebolavirus Is Internalized into Host Cells via Macropinocytosis in a Viral Glycoprotein-Dependent Manner (2010) (394)
- Transmission of SARS-CoV-2 in Domestic Cats. (2020) (393)
- Characterization of H7N9 influenza A viruses isolated from humans (2013) (392)
- Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: amino acid sequence at the HA cleavage site as a marker of pathogenicity potential. (1996) (371)
- Properties and Dissemination of H5N1 Viruses Isolated during an Influenza Outbreak in Migratory Waterfowl in Western China (2006) (363)
- Evolution and ecology of influenza A viruses (1992) (359)
- Identification of Amino Acids in HA and PB2 Critical for the Transmission of H5N1 Avian Influenza Viruses in a Mammalian Host (2009) (351)
- Ebola Virus VP40 Drives the Formation of Virus-Like Filamentous Particles Along with GP (2002) (350)
- Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin? (1984) (348)
- Growth of H5N1 Influenza A Viruses in the Upper Respiratory Tracts of Mice (2007) (334)
- Antibody‐dependent enhancement of viral infection: molecular mechanisms and in vivo implications (2003) (333)
- Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. (2013) (326)
- Cellular networks involved in the influenza virus life cycle. (2010) (323)
- At the centre: influenza A virus ribonucleoproteins (2014) (317)
- Is the gene pool of influenza viruses in shorebirds and gulls different from that in wild ducks? (1988) (315)
- Selective incorporation of influenza virus RNA segments into virions (2003) (314)
- Biological and Structural Characterization of a Host-Adapting Amino Acid in Influenza Virus (2010) (307)
- Human infection with highly pathogenic H5N1 influenza virus (2008) (307)
- The Potential for Respiratory Droplet–Transmissible A/H5N1 Influenza Virus to Evolve in a Mammalian Host (2012) (306)
- Host Range Restriction and Pathogenicity in the Context of Influenza Pandemic (2006) (305)
- In This Issue (2005) (303)
- Biological Heterogeneity, Including Systemic Replication in Mice, of H5N1 Influenza A Virus Isolates from Humans in Hong Kong (1999) (300)
- Influenza A virus NS2 protein mediates vRNP nuclear export through NES‐independent interaction with hCRM1 (2000) (294)
- Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus (1994) (292)
- Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins (1991) (289)
- Inhibition of Lassa and Marburg Virus Production by Tetherin (2008) (282)
- Perpetuation of influenza A viruses in Alaskan waterfowl reservoirs (2005) (274)
- Ebola Virus VP40-Induced Particle Formation and Association with the Lipid Bilayer (2001) (272)
- Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation (2021) (270)
- Tyro3 Family-Mediated Cell Entry of Ebola and Marburg Viruses (2006) (268)
- SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters (2022) (267)
- Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. (1997) (266)
- The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. (2005) (264)
- The Role of Influenza A Virus Hemagglutinin Residues 226 and 228 in Receptor Specificity and Host Range Restriction (1998) (264)
- The pathogenesis of influenza virus infections: the contributions of virus and host factors. (2011) (258)
- The role of receptor binding specificity in interspecies transmission of influenza viruses. (2012) (256)
- Human Macrophage C-Type Lectin Specific for Galactose and N-Acetylgalactosamine Promotes Filovirus Entry (2004) (255)
- An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies (2022) (251)
- Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. (1988) (249)
- Pathogenic Influenza Viruses and Coronaviruses Utilize Similar and Contrasting Approaches To Control Interferon-Stimulated Gene Responses (2014) (245)
- Origin and molecular changes associated with emergence of a highly pathogenic H5N2 influenza virus in Mexico. (1995) (244)
- Effectiveness of Face Masks in Preventing Airborne Transmission of SARS-CoV-2 (2020) (243)
- Characterization of virulent and avirulent A/chicken/Pennsylvania/83 influenza A viruses: potential role of defective interfering RNAs in nature (1985) (242)
- A novel mechanism for the acquisition of virulence by a human influenza A virus. (1998) (239)
- CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin. (2013) (235)
- Vaccination with a Recombinant Vesicular Stomatitis Virus Expressing an Influenza Virus Hemagglutinin Provides Complete Protection from Influenza Virus Challenge (1998) (234)
- Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts (1992) (234)
- Identification of Novel Influenza A Virus Proteins Translated from PA mRNA (2012) (233)
- Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir. (1993) (231)
- Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. (2007) (229)
- Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA. (2011) (225)
- Influenza virus-host interactome screen as a platform for antiviral drug development. (2014) (224)
- Antibodies are necessary for rVSV/ZEBOV-GP–mediated protection against lethal Ebola virus challenge in nonhuman primates (2013) (223)
- Biologic importance of neuraminidase stalk length in influenza A virus (1993) (223)
- Contributions of Two Nuclear Localization Signals of Influenza A Virus Nucleoprotein to Viral Replication (2006) (219)
- Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection (1997) (218)
- Evolution of influenza A virus nucleoprotein genes: implications for the origins of H1N1 human and classical swine viruses (1991) (216)
- Lethal Influenza Virus Infection in Macaques Is Associated with Early Dysregulation of Inflammatory Related Genes (2009) (215)
- Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus (2011) (214)
- Emergence of avian H1N1 influenza viruses in pigs in China (1996) (213)
- Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses (1994) (212)
- Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant (2022) (211)
- [Influenza virus receptors in the human airway]. (2006) (210)
- Characterization of a new avian-like influenza A virus from horses in China. (1992) (207)
- Genetics, Receptor Binding Property, and Transmissibility in Mammals of Naturally Isolated H9N2 Avian Influenza Viruses (2014) (204)
- Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography (2012) (204)
- An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies (2021) (203)
- Molecular Determinants of Ebola Virus Virulence in Mice (2006) (202)
- Reverse Genetics Demonstrates that Proteolytic Processing of the Ebola Virus Glycoprotein Is Not Essential for Replication in Cell Culture (2002) (201)
- Evolution of the nucleoprotein gene of influenza A virus (1990) (200)
- Nuclear import and export of influenza virus nucleoprotein (1997) (197)
- Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1 (2010) (196)
- T-705 (favipiravir) activity against lethal H5N1 influenza A viruses (2009) (195)
- Do hemagglutinin genes of highly pathogenic avian influenza viruses constitute unique phylogenetic lineages? (1995) (194)
- Structural Rearrangement of Ebola Virus VP40 Begets Multiple Functions in the Virus Life Cycle (2013) (194)
- Two amino acid residues in the matrix protein M1 contribute to the virulence difference of H5N1 avian influenza viruses in mice. (2009) (193)
- Antibody-Dependent Enhancement of Ebola Virus Infection (2003) (192)
- Characterization of H5N1 influenza A viruses isolated during the 2003-2004 influenza outbreaks in Japan. (2005) (192)
- Orthomyxovirus replication, transcription, and polyadenylation. (2004) (192)
- Importance of both the Coding and the Segment-Specific Noncoding Regions of the Influenza A Virus NS Segment for Its Efficient Incorporation into Virions (2005) (191)
- H5N1 influenza viruses: outbreaks and biological properties (2010) (190)
- Receptor binding by a ferret-transmissible H5 avian influenza virus (2013) (189)
- Exploitation of Nucleic Acid Packaging Signals To Generate a Novel Influenza Virus-Based Vector Stably Expressing Two Foreign Genes (2003) (187)
- Generation of a Highly Pathogenic Avian Influenza A Virus from an Avirulent Field Isolate by Passaging in Chickens (2001) (186)
- Hierarchy among Viral RNA (vRNA) Segments in Their Role in vRNA Incorporation into Influenza A Virions (2006) (186)
- The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner (2020) (184)
- Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. (2000) (183)
- Protective immunity against avian influenza induced by a fowlpox virus recombinant. (1988) (182)
- Nedd4 Regulates Egress of Ebola Virus-Like Particles from Host Cells (2003) (181)
- Infection of children with avian-human reassortant influenza virus from pigs in Europe. (1994) (179)
- Influenza Virus NS1 Protein Induces Apoptosis in Cultured Cells (2001) (176)
- An infectious disease of ducks caused by a newly emerged Tembusu virus strain in mainland China. (2011) (175)
- Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. (2007) (174)
- A Naturally Occurring Deletion in Its NS Gene Contributes to the Attenuation of an H5N1 Swine Influenza Virus in Chickens (2007) (174)
- The Cytoplasmic Tail of the Influenza A Virus M2 Protein Plays a Role in Viral Assembly (2006) (168)
- Assembly and Budding of Ebolavirus (2006) (168)
- Coinfection of wild ducks by influenza A viruses: distribution patterns and biological significance (1997) (167)
- A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned? (2002) (166)
- Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice. (2003) (165)
- A novel M cell–specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses (2007) (164)
- Ebola Virus Glycoprotein: Proteolytic Processing, Acylation, Cell Tropism, and Detection of Neutralizing Antibodies (2001) (164)
- A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus. (2018) (162)
- Continued evolution of H1N1 and H3N2 influenza viruses in pigs in Italy. (1997) (160)
- Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift (2021) (157)
- Enhanced Expression of an α2,6-Linked Sialic Acid on MDCK Cells Improves Isolation of Human Influenza Viruses and Evaluation of Their Sensitivity to a Neuraminidase Inhibitor (2005) (157)
- Three-dimensional analysis of ribonucleoprotein complexes in influenza A virus (2012) (156)
- Functional Mapping of the Nucleoprotein of Ebola Virus (2006) (156)
- Molecular characterization of a new hemagglutinin, subtype H14, of influenza A virus. (1990) (153)
- Recognition of N-Glycolylneuraminic Acid Linked to Galactose by the α2,3 Linkage Is Associated with Intestinal Replication of Influenza A Virus in Ducks (2000) (153)
- RAB11A Is Essential for Transport of the Influenza Virus Genome to the Plasma Membrane (2011) (152)
- Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2 (2022) (152)
- Cellular Factors Required for Lassa Virus Budding (2006) (151)
- Wild ducks are the reservoir for only a limited number of influenza A subtypes (1993) (149)
- Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection (2018) (148)
- Cross-Reactive T Cells Are Involved in Rapid Clearance of 2009 Pandemic H1N1 Influenza Virus in Nonhuman Primates (2011) (148)
- An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. (2005) (148)
- Influenza A virus isolation, culture and identification (2014) (147)
- Influenza A (H5N1) Viruses from Pigs, Indonesia (2010) (145)
- Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. (1991) (145)
- High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza. (2003) (145)
- DNA Vaccine Encoding Hemagglutinin Provides Protective Immunity against H5N1 Influenza Virus Infection in Mice (1999) (141)
- Reassortment between avian H5N1 and human H3N2 influenza viruses creates hybrid viruses with substantial virulence (2010) (141)
- Transmission of influenza A viruses. (2015) (141)
- The cytoplasmic tail of influenza A virus neuraminidase (NA) affects NA incorporation into virions, virion morphology, and virulence in mice but is not essential for virus replication (1996) (141)
- Mutational Analysis of the Putative Fusion Domain of Ebola Virus Glycoprotein (1999) (141)
- Host-range barrier of influenza A viruses. (2000) (140)
- Amino Acid Residues Contributing to the Substrate Specificity of the Influenza A Virus Neuraminidase (1999) (138)
- Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks (1997) (138)
- The Host Protease TMPRSS2 Plays a Major Role in In Vivo Replication of Emerging H7N9 and Seasonal Influenza Viruses (2014) (138)
- MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape (2018) (137)
- Comparison of Rapid Antigen Tests for COVID-19 (2020) (133)
- Identification of Cell Surface Molecules Involved in Dystroglycan-Independent Lassa Virus Cell Entry (2011) (133)
- Immunization with a Single Major Histocompatibility Complex Class I-Restricted Cytotoxic T-Lymphocyte Recognition Epitope of Herpes Simplex Virus Type 2 Confers Protective Immunity (1998) (133)
- "Ambisense" approach for the generation of influenza A virus: vRNA and mRNA synthesis from one template. (2000) (132)
- The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses (2016) (131)
- Production of Novel Ebola Virus-Like Particles from cDNAs: an Alternative to Ebola Virus Generation by Reverse Genetics (2004) (129)
- Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses (2010) (129)
- The spatio-temporal distribution dynamics of Ebola virus proteins and RNA in infected cells (2013) (128)
- Molecular analyses of the hemagglutinin genes of H5 influenza viruses: origin of a virulent turkey strain. (1987) (125)
- Influenza A Virus Polymerase Inhibits Type I Interferon Induction by Binding to Interferon β Promoter Stimulator 1* (2010) (125)
- Antigenic and genetic conservation of H3 influenza virus in wild ducks. (1987) (125)
- Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection (2019) (124)
- systemsDock: a web server for network pharmacology-based prediction and analysis (2016) (123)
- A Shared Structural Solution for Neutralizing Ebolaviruses (2011) (121)
- Functional Importance of the Coiled-Coil of the Ebola Virus Glycoprotein (2000) (120)
- Generation of velogenic Newcastle disease viruses from a nonpathogenic waterfowl isolate by passaging in chickens. (2002) (118)
- A Highly Pathogenic Avian H7N9 Influenza Virus Isolated from A Human Is Lethal in Some Ferrets Infected via Respiratory Droplets. (2017) (118)
- A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection (2009) (118)
- Interspecies transmission of influenza viruses: H5N1 virus and a Hong Kong SAR perspective. (2000) (117)
- Antibody titers against SARS-CoV-2 decline, but do not disappear for several months (2021) (117)
- Role of Transmembrane Domain and Cytoplasmic Tail Amino Acid Sequences of Influenza A Virus Neuraminidase in Raft Association and Virus Budding (2004) (116)
- Evolution of influenza A virus PB2 genes: implications for evolution of the ribonucleoprotein complex and origin of human influenza A virus (1990) (113)
- Influenza: interspecies transmission and emergence of new pandemics (1997) (112)
- Infectivity-Enhancing Antibodies to Ebola Virus Glycoprotein (2001) (111)
- A comprehensive map of the influenza A virus replication cycle (2013) (110)
- High Level of Genetic Compatibility between Swine-Origin H1N1 and Highly Pathogenic Avian H5N1 Influenza Viruses (2010) (110)
- Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genome. (2007) (110)
- The PA Protein Directly Contributes to the Virulence of H5N1 Avian Influenza Viruses in Domestic Ducks (2010) (110)
- Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters (2022) (109)
- Sequence specificity of furin, a proprotein-processing endoprotease, for the hemagglutinin of a virulent avian influenza virus (1994) (108)
- Generation of biologically contained Ebola viruses (2008) (107)
- Viral RNA polymerase complex promotes optimal growth of 1918 virus in the lower respiratory tract of ferrets (2009) (107)
- Evolution of the hemagglutinin of equine H3 influenza viruses. (1989) (106)
- Identification of Protective Epitopes on Ebola Virus Glycoprotein at the Single Amino Acid Level by Using Recombinant Vesicular Stomatitis Viruses (2003) (106)
- The draft genome sequence of the ferret (Mustela putorius furo) facilitates study of human respiratory disease (2014) (106)
- Selection of H5N1 Influenza Virus PB2 during Replication in Humans (2009) (106)
- Characterization of a Human H5N1 Influenza A Virus Isolated in 2003 (2005) (105)
- A Syrian golden hamster model recapitulating ebola hemorrhagic fever. (2013) (105)
- Interplay between carbohydrate in the stalk and the length of the connecting peptide determines the cleavability of influenza virus hemagglutinin (1989) (103)
- The mechanism of Axl-mediated Ebola virus infection. (2007) (102)
- Compatibility among Polymerase Subunit Proteins Is a Restricting Factor in Reassortment between Equine H7N7 and Human H3N2 Influenza Viruses (2008) (101)
- Rapid and simple detection of Ebola virus by reverse transcription-loop-mediated isothermal amplification. (2007) (100)
- Laboratory characterization of a swine influenza virus isolated from a fatal case of human influenza (1989) (100)
- Mutational Analysis of Conserved Amino Acids in the Influenza A Virus Nucleoprotein (2009) (100)
- Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants (2022) (99)
- The first influenza pandemic of the new millennium (2011) (98)
- Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2 (2022) (98)
- Plasminogen-Binding Activity of Neuraminidase Determines the Pathogenicity of Influenza A Virus (2001) (98)
- Molecular analysis of the hemagglutinin genes of Australian H7N7 influenza viruses: role of passerine birds in maintenance or transmission? (1987) (97)
- The Genome-Packaging Signal of the Influenza A Virus Genome Comprises a Genome Incorporation Signal and a Genome-Bundling Signal (2013) (97)
- Current and future influenza vaccines (2019) (97)
- Characterization of Oseltamivir-Resistant 2009 H1N1 Pandemic Influenza A Viruses (2010) (96)
- Ebola virus matrix protein VP40 uses the COPII transport system for its intracellular transport. (2008) (96)
- Key Molecular Factors in Hemagglutinin and PB2 Contribute to Efficient Transmission of the 2009 H1N1 Pandemic Influenza Virus (2012) (95)
- CTen: a web-based platform for identifying enriched cell types from heterogeneous microarray data (2012) (95)
- Virulence-Affecting Amino Acid Changes in the PA Protein of H7N9 Influenza A Viruses (2013) (95)
- Plasmid-Driven Formation of Influenza Virus-Like Particles (2000) (94)
- Continuing progress towards a unified nomenclature for the highly pathogenic H5N1 avian influenza viruses: Divergence of clade 2·2 viruses (2009) (94)
- Shedding of infectious SARS-CoV-2 despite vaccination (2021) (94)
- Distinct lineages of influenza virus H4 hemagglutinin genes in different regions of the world. (1989) (93)
- Protective neutralizing influenza antibody response in the absence of T follicular helper cells (2016) (92)
- Sialidase Activity of Influenza A Virus in an Endocytic Pathway Enhances Viral Replication (2005) (91)
- Pathological studies of chickens experimentally infected with two highly pathogenic avian influenza viruses. (1996) (91)
- Influenza A Virus Can Undergo Multiple Cycles of Replication without M2 Ion Channel Activity (2001) (91)
- Pandemic potential of avian influenza A (H7N9) viruses. (2014) (90)
- The quail and chicken intestine have sialyl-galactose sugar chains responsible for the binding of influenza A viruses to human type receptors. (2007) (90)
- Structure of influenza virus ribonucleoprotein complexes and their packaging into virions (2010) (90)
- Integrated Clinical, Pathologic, Virologic, and Transcriptomic Analysis of H5N1 Influenza Virus-Induced Viral Pneumonia in the Rhesus Macaque (2012) (90)
- H6 Influenza Viruses Pose a Potential Threat to Human Health (2014) (89)
- Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children. (2008) (89)
- Protective efficacy of neutralizing antibodies against Ebola virus infection. (2007) (89)
- Pandemic Swine-Origin H1N1 Influenza A Virus Isolates Show Heterogeneous Virulence in Macaques (2010) (88)
- Swine influenza virus strains recognize sialylsugar chains containing the molecular species of sialic acid predominantly present in the swine tracheal epithelium (1997) (88)
- The pathogenesis of Ebola hemorrhagic fever. (2001) (88)
- Annotation of long non-coding RNAs expressed in Collaborative Cross founder mice in response to respiratory virus infection reveals a new class of interferon-stimulated transcripts (2014) (88)
- Molecular changes in A/Chicken/Pennsylvania/83 (H5N2) influenza virus associated with acquisition of virulence. (1986) (88)
- Identification of a Novel Viral Protein Expressed from the PB2 Segment of Influenza A Virus (2015) (87)
- Multi-spectral fluorescent reporter influenza viruses (Color-flu) as powerful tools for in vivo studies (2015) (85)
- Influenza A variants with reduced susceptibility to baloxavir isolated from Japanese patients are fit and transmit through respiratory droplets (2019) (85)
- Co-infection with SARS-CoV-2 and influenza A virus (2020) (85)
- Prevalence, genetics, and transmissibility in ferrets of Eurasian avian-like H1N1 swine influenza viruses (2015) (84)
- Influence of host species on the evolution of the nonstructural (NS) gene of influenza A viruses. (1998) (84)
- Replication-Deficient Ebolavirus as a Vaccine Candidate (2009) (84)
- Emerging viral diseases. (2000) (84)
- Integrative Deep Sequencing of the Mouse Lung Transcriptome Reveals Differential Expression of Diverse Classes of Small RNAs in Response to Respiratory Virus Infection (2011) (84)
- The Cytoprotective Enzyme Heme Oxygenase-1 Suppresses Ebola Virus Replication (2013) (84)
- Application of Directigen FLU-A for the detection of influenza A virus in human and nonhuman specimens (1992) (84)
- Influenza--a model of an emerging virus disease. (1993) (84)
- Reverse genetics systems for the generation of segmented negative-sense RNA viruses entirely from cloned cDNA. (2004) (84)
- The HA and NS Genes of Human H5N1 Influenza A Virus Contribute to High Virulence in Ferrets (2010) (83)
- Strategies for developing vaccines against H5N1 influenza A viruses. (2006) (83)
- Influenza A Viruses Lacking Sialidase Activity Can Undergo Multiple Cycles of Replication in Cell Culture, Eggs, or Mice (2000) (83)
- Rescue of an influenza A virus wild-type PB2 gene and a mutant derivative bearing a site-specific temperature-sensitive and attenuating mutation (1993) (83)
- Isolation of a genotypically unique H5N1 influenza virus from duck meat imported into Japan from China. (2005) (82)
- Multi-platform 'Omics Analysis of Human Ebola Virus Disease Pathogenesis. (2017) (82)
- Nucleotide Sequence Requirements at the 5′ End of the Influenza A Virus M RNA Segment for Efficient Virus Replication (2009) (82)
- Efficacy of the New Neuraminidase Inhibitor CS-8958 against H5N1 Influenza Viruses (2010) (82)
- Use of Vesicular Stomatitis Virus Pseudotypes Bearing Hantaan or Seoul Virus Envelope Proteins in a Rapid and Safe Neutralization Test (2003) (81)
- Ebola Virus VP40 Late Domains Are Not Essential for Viral Replication in Cell Culture (2005) (81)
- Influenza Virology: Current Topics (2006) (81)
- Characterization of the Ebola virus nucleoprotein–RNA complex (2010) (81)
- Circulating avian influenza viruses closely related to the 1918 virus have pandemic potential. (2014) (80)
- Influenza viral infection of swine in the United States 1988–1989 (2005) (80)
- Host Regulatory Network Response to Infection with Highly Pathogenic H5N1 Avian Influenza Virus (2011) (80)
- Mutations in PA, NP, and HA of a pandemic (H1N1) 2009 influenza virus contribute to its adaptation to mice. (2011) (79)
- Development of high-yield influenza A virus vaccine viruses (2015) (78)
- Epitopes required for antibody-dependent enhancement of Ebola virus infection. (2007) (78)
- A Duck Enteritis Virus-Vectored Bivalent Live Vaccine Provides Fast and Complete Protection against H5N1 Avian Influenza Virus Infection in Ducks (2011) (78)
- In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein. (2007) (77)
- An Ebola whole-virus vaccine is protective in nonhuman primates (2015) (77)
- Sulphatide binds to human and animal influenza A viruses, and inhibits the viral infection. (1996) (77)
- Evolution of the A/Chicken/Pennsylvania/83 (H5N2) influenza virus. (1985) (77)
- Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets (2021) (77)
- Interspecies transmission and reassortment of influenza A viruses in pigs and turkeys in the United States. (1992) (76)
- SARS-CoV-2 infection severity is linked to superior humoral immunity against the spike (2020) (76)
- Cryo-EM structure of the Ebola virus nucleoprotein–RNA complex at 3.6 Å resolution (2018) (75)
- Adding Protein Context to the Human Protein-Protein Interaction Network to Reveal Meaningful Interactions (2013) (75)
- Selection on hemagglutinin imposes a bottleneck during mammalian transmission of reassortant H5N1 influenza viruses (2013) (75)
- A Network Integration Approach to Predict Conserved Regulators Related to Pathogenicity of Influenza and SARS-CoV Respiratory Viruses (2013) (75)
- Standardization of inactivated H5N2 influenza vaccine and efficacy against lethal A/Chicken/Pennsylvania/1370/83 infection. (1985) (74)
- Marburg Virus VP35 Can Both Fully Coat the Backbone and Cap the Ends of dsRNA for Interferon Antagonism (2012) (73)
- The NB Protein of Influenza B Virus Is Not Necessary for Virus Replication In Vitro (2003) (73)
- Complex Reassortment of Multiple Subtypes of Avian Influenza Viruses in Domestic Ducks at the Dongting Lake Region of China (2013) (73)
- Human trachea primary epithelial cells express both sialyl(α2-3)Gal receptor for human parainfluenza virus type 1 and avian influenza viruses, and sialyl(α2-6)Gal receptor for human influenza viruses (2006) (73)
- Attenuation of influenza A virus by insertion of a foreign epitope into the neuraminidase (1992) (72)
- Adaptation of an H7N7 equine influenza A virus in mice. (2007) (72)
- A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection. (2010) (72)
- Immunogenicity and Protective Efficacy of Replication-Incompetent Influenza Virus-Like Particles (2002) (72)
- Identification of mammalian-adapting mutations in the polymerase complex of an avian H5N1 influenza virus (2015) (72)
- The continued pandemic threat posed by avian influenza viruses in Hong Kong. (2002) (71)
- Mapping of the VP40-Binding Regions of the Nucleoprotein of Ebola Virus (2007) (71)
- Characterization of a Large Cluster of Influenza A(H1N1)pdm09 Viruses Cross-Resistant to Oseltamivir and Peramivir during the 2013-2014 Influenza Season in Japan (2015) (71)
- Characterization of a Neuraminidase-Deficient Influenza A Virus as a Potential Gene Delivery Vector and a Live Vaccine (2004) (71)
- Toll-like receptor pre-stimulation protects mice against lethal infection with highly pathogenic influenza viruses (2011) (70)
- Impact of Amino Acid Mutations in PB2, PB1-F2, and NS1 on the Replication and Pathogenicity of Pandemic (H1N1) 2009 Influenza Viruses (2011) (70)
- Subclinical Brain Injury Caused by H5N1 Influenza Virus Infection (2011) (70)
- Sensitivity of Influenza Rapid Diagnostic Tests to H5N1 and 2009 Pandemic H1N1 Viruses (2010) (70)
- An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by several therapeutic monoclonal antibodies (2021) (69)
- Local Not Systemic Modulation of Dendritic Cell S1P Receptors in Lung Blunts Virus-Specific Immune Responses to Influenza (2008) (69)
- Protection of chickens from lethal influenza infection by vaccinia-expressed hemagglutinin. (1988) (69)
- Novel Approach to the Development of Effective H5N1 Influenza A Virus Vaccines: Use of M2 Cytoplasmic Tail Mutants (2007) (69)
- Amino Acid Changes in Hemagglutinin Contribute to the Replication of Oseltamivir-Resistant H1N1 Influenza Viruses (2011) (68)
- The M2 Ectodomain Is Important for Its Incorporation into Influenza A Virions (1998) (68)
- Avian influenza virus transmission to mammals. (2014) (67)
- Seroepidemiological and molecular evidence for the presence of two H3N8 equine influenza viruses in China in 1993-94. (1995) (67)
- Pathogenesis of the 1918 Pandemic Influenza Virus (2011) (67)
- Increased risk of rhinovirus infection in children during the coronavirus disease‐19 pandemic (2021) (67)
- The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate. (2006) (67)
- Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains (2022) (66)
- Molecular mechanism of acquisition of virulence in influenza virus in nature. (1988) (66)
- F1Fo-ATPase, F-type proton-translocating ATPase, at the plasma membrane is critical for efficient influenza virus budding (2012) (65)
- Filovirus budding. (2004) (65)
- Integrated Omics Analysis of Pathogenic Host Responses during Pandemic H1N1 Influenza Virus Infection: The Crucial Role of Lipid Metabolism. (2016) (64)
- Molecular changes in virulent mutants arising from avirulent avian influenza viruses during replication in 14-day-old embryonated eggs. (1995) (64)
- Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2 (2022) (64)
- Role of host-specific amino acids in the pathogenicity of avian H5N1 influenza viruses in mice. (2010) (64)
- The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters (2021) (62)
- Herpes Simplex Virus 1 UL47 Interacts with Viral Nuclear Egress Factors UL31, UL34, and Us3 and Regulates Viral Nuclear Egress (2014) (62)
- Immunogenicity and Protective Efficacy of a Live Attenuated H5N1 Vaccine in Nonhuman Primates (2009) (62)
- Distinct glycoprotein inhibitors of influenza A virus in different animal sera (1991) (62)
- Imported Parakeets Harbor H9N2 Influenza A Viruses That Are Genetically Closely Related to Those Transmitted to Humans in Hong Kong (2001) (62)
- SARS-CoV-2 spike P681R mutation, a hallmark of the Delta variant, enhances viral fusogenicity and pathogenicity (2021) (62)
- Protection against lethal lymphocytic choriomeningitis virus (LCMV) infection by immunization of mice with an influenza virus containing an LCMV epitope recognized by cytotoxic T lymphocytes (1994) (62)
- Chemotherapy and vaccination: a possible strategy for the control of highly virulent influenza virus (1985) (61)
- Hemagglutinin Receptor Specificity and Structural Analyses of Respiratory Droplet-Transmissible H5N1 Viruses (2013) (61)
- Regions in Ebola virus VP24 that are important for nucleocapsid formation. (2007) (61)
- Pathogenicity of highly pathogenic avian influenza virus in mammals. (2008) (61)
- H5N1: Flu transmission work is urgent (2012) (60)
- Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses. (2011) (60)
- Enhanced Growth of Influenza Vaccine Seed Viruses in Vero Cells Mediated by Broadening the Optimal pH Range for Virus Membrane Fusion (2011) (60)
- Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir. (2016) (60)
- Influenza A Virus Lacking M2 Protein as a Live Attenuated Vaccine (2009) (60)
- Generation of Influenza A Virus NS2 (NEP) Mutants with an Altered Nuclear Export Signal Sequence (2004) (59)
- Replication-incompetent influenza A viruses that stably express a foreign gene. (2011) (59)
- Proteolytic Processing of the Ebola Virus Glycoprotein Is Not Critical for Ebola Virus Replication in Nonhuman Primates (2007) (58)
- Longitudinal antibody repertoire in “mild” versus “severe” COVID-19 patients reveals immune markers associated with disease severity and resolution (2021) (58)
- Defining the risk of SARS-CoV-2 variants on immune protection (2022) (58)
- Complete and Incomplete Genome Packaging of Influenza A and B Viruses (2016) (57)
- Selection of antigenically advanced variants of seasonal influenza viruses (2016) (57)
- Antigenic differences between H5N1 human influenza viruses isolated in 1997 and 2003. (2004) (57)
- Transmission of influenza A/H5N1 viruses in mammals. (2013) (57)
- Evolutionary pathways of the PA genes of influenza A viruses. (1989) (57)
- Viral Replication Rate Regulates Clinical Outcome and CD8 T Cell Responses during Highly Pathogenic H5N1 Influenza Virus Infection in Mice (2010) (57)
- Selective Bottlenecks Shape Evolutionary Pathways Taken during Mammalian Adaptation of a 1918-like Avian Influenza Virus (2016) (57)
- Lung-Derived Exosomal miR-483-3p Regulates the Innate Immune Response to Influenza Virus Infection (2018) (56)
- Syrian Hamster as an Animal Model for the Study of Human Influenza Virus Infection (2017) (56)
- Inhibition of Marburg Virus Budding by Nonneutralizing Antibodies to the Envelope Glycoprotein (2012) (56)
- Continued circulation of reassortant H1N2 influenza viruses in pigs in Japan (1998) (55)
- Comparative Study of Influenza Virus Replication in MDCK Cells and in Primary Cells Derived from Adenoids and Airway Epithelium (2012) (55)
- Protective efficacy of orally administered, heat-killed Lactobacillus pentosus b240 against influenza A virus (2013) (55)
- The TLR4-TRIF Pathway Protects against H5N1 Influenza Virus Infection (2011) (55)
- Importance of conserved amino acids at the cleavage site of the haemagglutinin of a virulent avian influenza A virus. (1993) (55)
- A comparison of the pathogenicity of avian and swine H5N1 influenza viruses in Indonesia (2009) (54)
- Molecular Mechanisms of Serum Resistance of Human Influenza H3N2 Virus and Their Involvement in Virus Adaptation in a New Host (1998) (54)
- Enhanced growth of seed viruses for H5N1 influenza vaccines. (2007) (54)
- A humanized MDCK cell line for the efficient isolation and propagation of human influenza viruses (2019) (54)
- Egyptian H5N1 Influenza Viruses—Cause for Concern? (2012) (54)
- Pandemic potential of highly pathogenic avian influenza clade 2.3.4.4 A(H5) viruses (2020) (54)
- Tissue-specific subnetworks and characteristics of publicly available human protein interaction databases (2011) (54)
- Reverse genetics system for generation of an influenza A virus mutant containing a deletion of the carboxyl-terminal residue of M2 protein (1995) (54)
- Amino Acids Responsible for the Absolute Sialidase Activity of the Influenza A Virus Neuraminidase: Relationship to Growth in the Duck Intestine (2001) (53)
- Characterization of a new SARS-CoV-2 variant that emerged in Brazil (2021) (53)
- Functional Analysis of Conserved Motifs in Influenza Virus PB1 Protein (2012) (53)
- Novel residues in avian influenza virus PB2 protein affect virulence in mammalian hosts (2014) (52)
- Equine H7N7 influenza A viruses are highly pathogenic in mice without adaptation: potential use as an animal model (1991) (52)
- Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors. (2011) (52)
- Virulent influenza A viruses induce apoptosis in chickens. (2002) (52)
- Highly Pathogenic H5N1 Influenza Virus Causes Coagulopathy in Chickens (2006) (51)
- Growth Determinants for H5N1 Influenza Vaccine Seed Viruses in MDCK Cells (2008) (51)
- Influenza virus-host interactomes as a basis for antiviral drug development. (2015) (51)
- A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques. (2008) (51)
- Gargle Lavage as a Safe and Sensitive Alternative to Swab Samples to Diagnose COVID-19: A Case Report in Japan (2020) (50)
- A Role for the C Terminus of Mopeia Virus Nucleoprotein in Its Incorporation into Z Protein-Induced Virus-Like Particles (2010) (50)
- Plasma lipidome reveals critical illness and recovery from human Ebola virus disease (2019) (50)
- Development and deployment of COVID-19 vaccines for those most vulnerable (2021) (49)
- Role for a cortical input to hippocampal area CA 1 in the consolidation of a long-termmemory (2004) (49)
- Location and character of the cellular enzyme that cleaves the hemagglutinin of a virulent avian influenza virus. (1992) (48)
- Oseltamivir-Resistant Influenza A Viruses Circulating in Japan (2009) (48)
- Pause on avian flu transmission studies (2012) (48)
- Human influenza a viral genes responsible for the restriction of its replication in duck intestine. (2002) (48)
- Disease Severity Is Associated with Differential Gene Expression at the Early and Late Phases of Infection in Nonhuman Primates Infected with Different H5N1 Highly Pathogenic Avian Influenza Viruses (2014) (48)
- SARS-CoV-2 D614G Variant Exhibits Enhanced Replication ex vivo and Earlier Transmission in vivo (2020) (48)
- A Broadly Reactive Human Anti-hemagglutinin Stem Monoclonal Antibody That Inhibits Influenza A Virus Particle Release (2017) (47)
- Mutation Analysis of 2009 Pandemic Influenza A(H1N1) Viruses Collected in Japan during the Peak Phase of the Pandemic (2011) (46)
- Structure of an Antibody in Complex with Its Mucin Domain Linear Epitope That Is Protective against Ebola Virus (2011) (46)
- The importance of the NP: VP35 ratio in Ebola virus nucleocapsid formation. (2011) (46)
- Synergistic Effect of the PDZ and p85β-Binding Domains of the NS1 Protein on Virulence of an Avian H5N1 Influenza A Virus (2013) (46)
- Alpha 2-macroglobulin is the major neutralizing inhibitor of influenza A virus in pig serum. (1993) (46)
- Mutations in the cytoplasmic tail of influenza A virus neuraminidase affect incorporation into virions (1993) (46)
- Systemic Dissemination of H5N1 Influenza A Viruses in Ferrets and Hamsters after Direct Intragastric Inoculation (2011) (45)
- Different Potential of C-Type Lectin-Mediated Entry between Marburg Virus Strains (2010) (45)
- Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck (2021) (45)
- Conserved host response to highly pathogenic avian influenza virus infection in human cell culture, mouse and macaque model systems (2011) (45)
- Establishment of Canine RNA Polymerase I-Driven Reverse Genetics for Influenza A Virus: Its Application for H5N1 Vaccine Production (2007) (45)
- The Early Expression of Glycoprotein B from Herpes Simplex Virus Can Be Detected by Antigen-Specific CD8+ T Cells (2003) (45)
- Substitution of amino acid residue in influenza A virus hemagglutinin affects recognition of sialyl‐oligosaccharides containing N‐glycolylneuraminic acid (1999) (45)
- Prospective systematic study of Yersinia spp. in dogs (1984) (45)
- Pathogenicity of highly pathogenic avian H5N1 influenza A viruses isolated from humans between 2003 and 2008 in northern Vietnam (2010) (44)
- Amino acids substitutions in the PB2 protein of H7N9 influenza A viruses are important for virulence in mammalian hosts (2015) (44)
- Detection of Cell-Cell Fusion Mediated by Ebola Virus Glycoproteins (2006) (44)
- Importance of the 1+7 configuration of ribonucleoprotein complexes for influenza A virus genome packaging (2018) (44)
- Configuration of Viral Ribonucleoprotein Complexes within the Influenza A Virion (2013) (44)
- Mapping of a Region of the PA-X Protein of Influenza A Virus That Is Important for Its Shutoff Activity (2015) (44)
- A comprehensive collection of systems biology data characterizing the host response to viral infection (2014) (43)
- Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcγRIIA and FcγRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages (2021) (43)
- Minigenome-Based Reporter System Suitable for High-Throughput Screening of Compounds Able To Inhibit Ebolavirus Replication and/or Transcription (2010) (43)
- Functional Genomics Reveals the Induction of Inflammatory Response and Metalloproteinase Gene Expression during Lethal Ebola Virus Infection (2011) (42)
- Nucleocapsid-like structures of Ebola virus reconstructed using electron tomography. (2005) (42)
- Low Polymerase Activity Attributed to PA Drives the Acquisition of the PB2 E627K Mutation of H7N9 Avian Influenza Virus in Mammals (2019) (41)
- The Ebolavirus VP24 protein blocks phosphorylation of p38 mitogen-activated protein kinase. (2011) (41)
- Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB (2022) (41)
- Pause on avian flu transmission research. (2012) (41)
- Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck (2020) (40)
- Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine. (2012) (40)
- Intestinal replication of influenza A viruses in two mammalian species (2005) (40)
- The cysteine residues of the M2 protein are not required for influenza A virus replication. (1997) (40)
- Changes in H3 influenza A virus receptor specificity during replication in humans. (1998) (40)
- Mapping SARS-CoV-2 antigenic relationships and serological responses (2022) (40)
- Phylogenetic characterization of H5N1 avian influenza viruses isolated in Indonesia from 2003-2007. (2009) (40)
- Growth temperature-dependent variation in the bacteriophage-inactivating capacity and antigenicity of Yersinia enterocolitica lipopolysaccharide. (1983) (40)
- Packaging of influenza virus genome: Robustness of selection (2012) (39)
- Influenza C and D Viruses Package Eight Organized Ribonucleoprotein Complexes (2018) (39)
- Adaptation of Influenza A Viruses to Cells Expressing Low Levels of Sialic Acid Leads to Loss of Neuraminidase Activity (2001) (39)
- Identification of Amino Acid Changes That May Have Been Critical for the Genesis of A(H7N9) Influenza Viruses (2014) (39)
- ALIX/AIP1 Is Required for NP Incorporation into Mopeia Virus Z-Induced Virus-Like Particles (2011) (39)
- Glycosylation of the Hemagglutinin Protein of H5N1 Influenza Virus Increases Its Virulence in Mice by Exacerbating the Host Immune Response (2017) (38)
- Effect of an Asparagine-to-Serine Mutation at Position 294 in Neuraminidase on the Pathogenicity of Highly Pathogenic H5N1 Influenza A Virus (2011) (38)
- The hemagglutinin cleavability of a virulent avian influenza virus by subtilisin-like endoproteases is influenced by the amino acid immediately downstream of the cleavage site. (1995) (38)
- 1918 Influenza Virus Hemagglutinin (HA) and the Viral RNA Polymerase Complex Enhance Viral Pathogenicity, but Only HA Induces Aberrant Host Responses in Mice (2013) (38)
- Reverse genetics of influenza virus. (2001) (38)
- Cell surface molecules involved in infection mediated by lymphocytic choriomeningitis virus glycoprotein. (2012) (37)
- Modified Vaccinia Virus Ankara Encoding Influenza Virus Hemagglutinin Induces Heterosubtypic Immunity in Macaques (2014) (37)
- Dogs are highly susceptible to H5N1 avian influenza virus. (2010) (37)
- Pneumo- and neurotropism of avian origin Italian highly pathogenic avian influenza H7N1 isolates in experimentally infected mice. (2007) (37)
- Incorporation of influenza A virus genome segments does not absolutely require wild-type sequences. (2009) (37)
- Rapid and accurate detection of novel coronavirus SARS-CoV-2 using CRISPR-Cas3 (2020) (37)
- Ultracentrifugation deforms unfixed influenza A virions. (2011) (37)
- Influenza A virus with defective M2 ion channel activity as a live vaccine. (2002) (37)
- Transmission Studies Resume for Avian Flu (2013) (37)
- Cleavability of hemagglutinin from an extremely virulent strain of avian influenza virus containing a unique cleavage site sequence. (1995) (37)
- Antigenic and molecular characterization of subtype H13 hemagglutinin of influenza virus. (1989) (36)
- Antigenic drift originating from changes to the lateral surface of the neuraminidase head of influenza A virus (2019) (36)
- Crystal Structure of Marburg Virus VP40 Reveals a Broad, Basic Patch for Matrix Assembly and a Requirement of the N-Terminal Domain for Immunosuppression (2015) (36)
- Biologic effects of introducing additional basic amino acid residues into the hemagglutinin cleavage site of a virulent avian influenza virus. (1997) (36)
- Characterization and pathogenicity of Yersinia pseudotuberculosis isolated from swine and other animals (1984) (36)
- Influenza B Virus Requires BM2 Protein for Replication (2004) (36)
- Biology of Negative Strand RNA Viruses: The Power of Reverse Genetics (2004) (36)
- Highly Pathogenic Avian Influenza Virus Infection in Feral Raccoons, Japan (2011) (36)
- Reassortment between Seasonal H1N1 and Pandemic (H1N1) 2009 Influenza Viruses Is Restricted by Limited Compatibility among Polymerase Subunits (2011) (36)
- The landscape of antibody binding in SARS-CoV-2 infection (2021) (35)
- A Single-Amino-Acid Substitution in the NS1 Protein Changes the Pathogenicity of H5N1 Avian Influenza Viruses in Mice (2008) (35)
- Induction of cytotoxic T‐lymphocyte and antibody responses against highly pathogenic avian influenza virus infection in mice by inoculation of apathogenic H5N1 influenza virus particles inactivated with formalin (2008) (35)
- Avian-Type Receptor-Binding Ability Can Increase Influenza Virus Pathogenicity in Macaques (2011) (35)
- Revealing fine-scale spatiotemporal differences in SARS-CoV-2 introduction and spread (2020) (35)
- A vaccine prepared from a non-pathogenic H7N7 virus isolated from natural reservoir conferred protective immunity against the challenge with lethal dose of highly pathogenic avian influenza virus in chickens. (2008) (35)
- Antigenicity of the N8 influenza A virus neuraminidase: existence of an epitope at the subunit interface of the neuraminidase (1994) (34)
- Epidemiology and control of human and animal influenza. (2006) (34)
- Mapping of a region of Ebola virus VP40 that is important in the production of virus-like particles. (2007) (34)
- Accuracy and stability of saliva as a sample for reverse transcription PCR detection of SARS-CoV-2 (2020) (34)
- Rescue of Ebola virus from cDNA using heterologous support proteins. (2004) (34)
- N-Terminal Acetylation by NatB Is Required for the Shutoff Activity of Influenza A Virus PA-X. (2018) (34)
- Genetic engineering of influenza and other negative-strand RNA viruses containing segmented genomes. (1999) (34)
- Emergence of a potentially pathogenic H5N2 influenza virus in chickens. (1994) (34)
- Assessment of retrovirus-expressed nucleoprotein as a vaccine against lethal influenza virus infections of chickens. (1992) (33)
- M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice. (2016) (33)
- Mutations affecting the sensitivity of the influenza virus neuraminidase to 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid. (1997) (33)
- Ebola virus requires a host scramblase for externalization of phosphatidylserine on the surface of viral particles (2018) (33)
- Pathogenicity of Chinese H5N1 highly pathogenic avian influenza viruses in pigeons (2008) (33)
- Gain-of-Function Experiments on H7N9 (2013) (33)
- Influenza A virus nucleoprotein is acetylated by histone acetyltransferases PCAF and GCN5 (2018) (33)
- Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines (2016) (32)
- Protection of ferrets from pulmonary injury due to H1N1 2009 influenza virus infection: immunopathology tractable by sphingosine-1-phosphate 1 receptor agonist therapy. (2014) (32)
- Analysis of Lujo Virus Cell Entry using Pseudotype Vesicular Stomatitis Virus (2014) (32)
- Competitive Incorporation of Homologous Gene Segments of Influenza A Virus into Virions (2012) (32)
- Pause on Avian Flu Transmission Research (2012) (32)
- DNA Topoisomerase 1 Facilitates the Transcription and Replication of the Ebola Virus Genome (2013) (32)
- Predicting the Next Influenza Pandemics (2019) (32)
- Adaptation of a Duck Influenza A Virus in Quail (2011) (32)
- MPLEx: a method for simultaneous pathogen inactivation and extraction of samples for multi-omics profiling. (2017) (31)
- The Highly Conserved Arginine Residues at Positions 76 through 78 of Influenza A Virus Matrix Protein M1 Play an Important Role in Viral Replication by Affecting the Intracellular Localization of M1 (2011) (31)
- Attenuation of an influenza A virus due to alteration of its hemagglutinin-neuraminidase functional balance in mice (2013) (31)
- Ostrich Involvement in the Selection of H5N1 Influenza Virus Possessing Mammalian-Type Amino Acids in the PB2 Protein (2009) (31)
- RuvB-Like Protein 2 Is a Suppressor of Influenza A Virus Polymerases (2009) (31)
- Emerging influenza viruses: past and present. (2005) (31)
- Characterization of a Feline Influenza A(H7N2) Virus (2018) (30)
- Directed Fusion of Mesenchymal Stem Cells with Cardiomyocytes via VSV-G Facilitates Stem Cell Programming (2012) (30)
- Phylogenetic analysis of the N8 neuraminidase gene of influenza A viruses. (1993) (30)
- A Replication-Incompetent PB2-Knockout Influenza A Virus Vaccine Vector (2012) (30)
- The anticoagulant nafamostat potently inhibits SARS-CoV-2 infection in vitro: an existing drug with multiple possible therapeutic effects (2020) (30)
- Neuropathological studies of chickens infected with highly pathogenic avian influenza viruses. (1996) (30)
- Combination Therapy With Neuraminidase and Polymerase Inhibitors in Nude Mice Infected With Influenza Virus (2018) (30)
- Recurring and Adaptable Binding Motifs in Broadly Neutralizing Antibodies to Influenza Virus Are Encoded on the D3-9 Segment of the Ig Gene (2018) (30)
- Protein co-expression network analysis (ProCoNA) (2013) (30)
- An Ultrasensitive Mechanism Regulates Influenza Virus-Induced Inflammation (2015) (30)
- Comparison of different approaches to measuring influenza A virus-specific hemagglutination inhibition antibodies in the presence of serum inhibitors (1992) (30)
- Suppressor of Cytokine Signaling 3 Is an Inducible Host Factor That Regulates Virus Egress during Ebola Virus Infection (2015) (29)
- Pathogenicity for chickens of avian influenza viruses isolated from whistling swans and a black-tailed gull in Japan. (1982) (29)
- Enhanced Replication of Highly Pathogenic Influenza A(H7N9) Virus in Humans (2018) (29)
- Identification of PB2 Mutations Responsible for the Efficient Replication of H5N1 Influenza Viruses in Human Lung Epithelial Cells (2015) (29)
- Virulence Determinants of Pandemic A(H1N1)2009 Influenza Virus in a Mouse Model (2012) (29)
- A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades (2020) (29)
- Characterization of Ebolavirus regulatory genomic regions. (2009) (29)
- Receptor specificity of influenza A viruses from sea mammals correlates with lung sialyloligosaccharides in these animals. (1999) (28)
- Cross talk between animal and human influenza viruses. (2013) (28)
- Molecular Pathogenesis of H5N1 Influenza Virus Infections (2005) (28)
- ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury (2020) (28)
- Reassortment between seasonal and swine-origin H1N1 influenza viruses generates viruses with enhanced growth capability in cell culture. (2011) (28)
- The Low-pH Stability Discovered in Neuraminidase of 1918 Pandemic Influenza A Virus Enhances Virus Replication (2010) (28)
- Are there alternative avian influenza viruses for generation of stable attenuated avian-human influenza A reassortant viruses? (1995) (28)
- Mammalian Adaptive Mutations of the PA Protein of Highly Pathogenic Avian H5N1 Influenza Virus (2015) (28)
- Influenza—an emerging and re-emerging disease (1994) (27)
- Direct reverse transcriptase PCR to determine virulence potential of influenza A viruses in birds (1995) (27)
- Imaging of influenza virus sialidase activity in living cells (2014) (27)
- One-Step Detection of the 2009 Pandemic Influenza A(H1N1) Virus by the RT-SmartAmp Assay and Its Clinical Validation (2012) (27)
- Induction of TNF-α in human macrophages by avian and human influenza viruses (2010) (27)
- Mucosal and Systemic Immune Responses to a Human Immunodeficiency Virus Type 1 Epitope Induced upon Vaginal Infection with a Recombinant Influenza A Virus (2004) (27)
- Protective Efficacy of Passive Immunization with Monoclonal Antibodies in Animal Models of H5N1 Highly Pathogenic Avian Influenza Virus Infection (2014) (27)
- Influenza viral hemagglutinin complicated shape is advantageous to its binding affinity for sialosaccharide receptor. (2007) (27)
- Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB (2022) (26)
- M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza. (2017) (26)
- Hypergraph models of biological networks to identify genes critical to pathogenic viral response (2020) (26)
- A Novel Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice from Pandemic H1N1 and Highly Pathogenic H5N1 Virus Challenges (2013) (26)
- Generation of Influenza A Viruses with Chimeric (Type A/B) Hemagglutinins (2003) (26)
- The 1918 Influenza Virus PB2 Protein Enhances Virulence through the Disruption of Inflammatory and Wnt-Mediated Signaling in Mice (2015) (26)
- Vaccination as a strategy to reduce the emergence of amantadine- and rimantadine-resistant strains of A/Chick/Pennsylvania/83 (H5N2) influenza virus. (1986) (26)
- Molecular characterization of the hemagglutinin and neuraminidase genes of H5N1 influenza A viruses isolated from poultry in Vietnam from 2004 to 2005. (2006) (26)
- Designing vaccines for pandemic influenza. (2009) (26)
- Live Bivalent Vaccine for Parainfluenza and Influenza Virus Infections (2005) (25)
- Structure-based design of NS2 mutants for attenuated influenza A virus vaccines. (2011) (25)
- Role of the GTPase Rab1b in Ebolavirus Particle Formation (2010) (25)
- Identification of amino acid residues of influenza A virus H3 HA contributing to the recognition of molecular species of sialic acid (2009) (25)
- Radioimmunoassay system using a serovar-specific lipopolysaccharide antigen of Leptospira (1979) (25)
- Avian flu: Gain-of-function experiments on H7N9 (2013) (25)
- In vivo imaging of the pathophysiological changes and neutrophil dynamics in influenza virus-infected mouse lungs (2018) (25)
- An M2 cytoplasmic tail mutant as a live attenuated influenza vaccine against pandemic (H1N1) 2009 influenza virus. (2011) (25)
- How Ebola virus infects cells. (2005) (24)
- Integrated network analysis reveals a novel role for the cell cycle in 2009 pandemic influenza virus-induced inflammation in macaque lungs (2012) (24)
- Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza A viruses. (2013) (24)
- Isolation of Yersinia spp. from bovine feces (1983) (24)
- What is the potential of avirulent influenza viruses to complement a cleavable hemagglutinin and generate virulent strains? (1989) (24)
- Cross-clade protective immunity of H5N1 influenza vaccines in a mouse model. (2008) (24)
- Influenza A virus hemagglutinin containing basolateral localization signal does not alter the apical budding of a recombinant influenza A virus in polarized MDCK cells. (2003) (23)
- The ASK family kinases differentially mediate induction of type I interferon and apoptosis during the antiviral response (2015) (23)
- Protection against H5N1 Highly Pathogenic Avian and Pandemic (H1N1) 2009 Influenza Virus Infection in Cynomolgus Monkeys by an Inactivated H5N1 Whole Particle Vaccine (2013) (22)
- Characterizing Emerging Canine H3 Influenza Viruses (2020) (22)
- Reverse Genetics for the Control of Avian Influenza (2003) (22)
- Comparison of two strains of avian infectious bronchitis virus for their interferon induction, viral growth and development of virus-neutralizing antibody in experimentally-infected chickens. (1987) (22)
- Generation of influenza A virus from cloned cDNAs — historical perspective and outlook for the new millenium (2002) (22)
- sGP serves as a structural protein in Ebola virus infection. (2011) (22)
- Mutations in NA That Induced Low pH-Stability and Enhanced the Replication of Pandemic (H1N1) 2009 Influenza A Virus at an Early Stage of the Pandemic (2013) (22)
- Isolation of influenza A viruses from migratory waterfowls in San-in District, Western Japan in 1979-1980. (1981) (22)
- Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization (2020) (22)
- Differences in cytokine production in human macrophages and in virulence in mice are attributable to the acidic polymerase protein of highly pathogenic influenza A virus subtype H5N1. (2013) (22)
- Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity. (2018) (21)
- High Levels of miR-483-3p Are Present in Serum Exosomes Upon Infection of Mice With Highly Pathogenic Avian Influenza Virus (2020) (21)
- Intrinsic Temperature Sensitivity of Influenza C Virus Hemagglutinin-Esterase-Fusion Protein (2012) (21)
- Network-Guided Discovery of Influenza Virus Replication Host Factors (2018) (21)
- Interactions between T Cells Responding to Concurrent Mycobacterial and Influenza Infections1 (2006) (21)
- Identification of Stabilizing Mutations in an H5 Hemagglutinin Influenza Virus Protein (2015) (21)
- Human Immunodeficiency Virus Rev-Binding Protein Is Essential for Influenza A Virus Replication and Promotes Genome Trafficking in Late-Stage Infection (2011) (21)
- Reverse genetics of influenza viruses. (2012) (21)
- Limited compatibility between the RNA polymerase components of influenza virus type A and B. (2008) (21)
- An H5N1 highly pathogenic avian influenza virus isolated from a local tree sparrow in Indonesia (2011) (20)
- The role of reverse genetics systems in studying viral hemorrhagic fevers (2005) (20)
- Specific mutations in H5N1 mainly impact the magnitude and velocity of the host response in mice (2013) (20)
- Identification of novel amino acid residues of influenza virus PA-X that are important for PA-X shutoff activity by using yeast. (2018) (20)
- Correlation Analysis between Gut Microbiota Alterations and the Cytokine Response in Patients with Coronavirus Disease during Hospitalization (2022) (20)
- Identification of amino acids in Marburg virus VP40 that are important for virus-like particle budding. (2011) (20)
- A Novel Functional Site in the PB2 Subunit of Influenza A Virus Essential for Acetyl-CoA Interaction, RNA Polymerase Activity, and Viral Replication* (2014) (20)
- Replacement of internal protein genes, with the exception of the matrix, in equine 1 viruses by equine 2 influenza virus genes during evolution in nature. (1999) (20)
- Intracellular localization of human immunodeficiency virus type 1 Gag and GagPol products and virus particle release: relationship with the Gag‐to‐GagPol ratio (2010) (19)
- Neurovirulence of H7N7 influenza A virus: Brain stem encephalitis accompanied with aspiration pneumonia in mice (2005) (19)
- Diversity of antigenic mutants of influenza A(H1N1)pdm09 virus escaped from human monoclonal antibodies (2017) (19)
- C646, a Novel p300/CREB-Binding Protein-Specific Inhibitor of Histone Acetyltransferase, Attenuates Influenza A Virus Infection (2015) (19)
- An Adenovirus Vector-Mediated Reverse Genetics System for Influenza A Virus Generation (2007) (19)
- Structural features influencing hemagglutinin cleavability in a human influenza A virus (1991) (19)
- Detection sensitivity of influenza rapid diagnostic tests (2014) (19)
- A cell-based screening system for influenza A viral RNA transcription/replication inhibitors (2013) (19)
- Inside the Cell: Assembly of Filoviruses. (2017) (19)
- A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus. (2020) (19)
- COVID-19 cynomolgus macaque model reflecting human COVID-19 pathological conditions (2021) (19)
- Multicolor two-photon imaging of in vivo cellular pathophysiology upon influenza virus infection using the two-photon IMPRESS (2020) (19)
- Distinct B cell subsets give rise to antigen-specific antibody responses against SARS-CoV-2 (2020) (19)
- Identification of interferon-stimulated genes that attenuate Ebola virus infection (2020) (19)
- Selection on haemagglutinin imposes a bottleneck during mammalian transmission of reassortant H 5 N 1 influenza viruses (2013) (18)
- Efficacy of Repeated Intravenous Administration of Peramivir against Highly Pathogenic Avian Influenza A (H5N1) Virus in Cynomolgus Macaques (2014) (18)
- Glycosylation and an amino acid insertion in the head of hemagglutinin independently affect the antigenic properties of H5N1 avian influenza viruses (2018) (18)
- Integrating Transcriptomic and Proteomic Data Using Predictive Regulatory Network Models of Host Response to Pathogens (2016) (18)
- H5N1 virus: Transmission studies resume for avian flu (2013) (18)
- Mutations in the PA Protein of Avian H5N1 Influenza Viruses Affect Polymerase Activity and Mouse Virulence (2017) (18)
- HEL-Flu: an influenza virus containing the hen egg lysozyme epitope recognized by CD4+ T cells from mice transgenic for an alphabeta TCR. (1997) (18)
- Isolation of Antigenically Active Components from Leptospiral Serovar‐Specific Lipopoly‐saccharide Antigen by Alkaline Treatment (1981) (18)
- The index influenza A virus subtype H5N1 isolated from a human in 1997 differs in its receptor-binding properties from a virulent avian influenza virus. (2004) (18)
- Molecular Determinants of Virulence and Stability of a Reporter-Expressing H5N1 Influenza A Virus (2015) (18)
- Interferon induction by several strains of avian infectious bronchitis virus, a coronavirus, in chickens. (1988) (18)
- Amino Acid Changes in the Influenza A Virus PA Protein That Attenuate Avian H5N1 Viruses in Mammals (2014) (18)
- Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses (2022) (17)
- Influenza viruses: an introduction. (2012) (17)
- Mitogen-Activated Protein Kinase-Activated Kinase RSK2 Plays a Role in Innate Immune Responses to Influenza Virus Infection (2009) (17)
- Durability of immune responses to the BNT162b2 mRNA vaccine (2021) (17)
- Cryo-EM structure of the Ebola virus nucleoprotein-RNA complex at 3.6 angstrom resolution. (2018) (17)
- Protective Immunity and Persistent Lung Sequelae in Domestic Cats after SARS-CoV-2 Infection (2021) (17)
- Taming influenza viruses. (2011) (17)
- The Pause on Avian H5N1 Influenza Virus Transmission Research Should Be Ended (2012) (17)
- A replication-incompetent virus possessing an uncleavable hemagglutinin as an influenza vaccine. (2012) (17)
- The Marmoset as an Animal Model of Influenza: Infection With A(H1N1)pdm09 and Highly Pathogenic A(H5N1) Viruses via the Conventional or Tracheal Spray Route (2018) (17)
- Differences in the ease with which mutant viruses escape from human monoclonal antibodies against the HA stem of influenza A virus. (2018) (16)
- Isolation of an Hswl Nav4 Influenza Virus from a Tufted Duck (Aythya fuligula) in Japan (1981) (16)
- Epidemiological study of Yersinia enterocolitica and Yersinia pseudotuberculosis infections in Shimane Prefecture, Japan. (1985) (16)
- Genetic and antigenic characterisation of influenza A(H3N2) viruses isolated in Yokohama during the 2016/17 and 2017/18 influenza seasons (2019) (16)
- SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike (2021) (16)
- A Critical Domain of Ebolavirus Envelope Glycoprotein Determines Glycoform and Infectivity (2018) (16)
- Risk assessment of recent Egyptian H5N1 influenza viruses (2016) (16)
- Hemozoin as a novel adjuvant for inactivated whole virion influenza vaccine. (2014) (16)
- The Microminipig as an Animal Model for Influenza A Virus Infection (2016) (16)
- Cross neutralization of emerging SARS-CoV-2 variants of concern by antibodies targeting distinct epitopes on spike (2021) (16)
- The Cellular Factors Vps18 and Mon2 Are Required for Efficient Production of Infectious HIV-1 Particles (2011) (16)
- Comparison between virus Shedding and Fever Duration after Treating Children with Pandemic a H1N1/09 and Children with a H3N2 with a Neuraminidase Inhibitor (2015) (16)
- Loss of Interleukin 1 Receptor Antagonist Enhances Susceptibility to Ebola Virus Infection. (2015) (16)
- Reactivity and sensitivity of commercially available influenza rapid diagnostic tests in Japan (2017) (16)
- Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice. (2012) (16)
- Emergence of Oseltamivir-Resistant H7N9 Influenza Viruses in Immunosuppressed Cynomolgus Macaques (2017) (15)
- Requirement for Siva-1 for replication of influenza A virus through apoptosis induction. (2011) (15)
- Accuracy of rapid antigen detection test for nasopharyngeal swab specimens and saliva samples in comparison with RT-PCR and viral culture for SARS-CoV-2 detection (2021) (15)
- Emerging and Reemerging Influenza Virus Infections (2010) (15)
- Ebola Virus Stability Under Hospital and Environmental Conditions. (2016) (15)
- Characterization In Vitro and In Vivo of Pandemic (H1N1) 2009 Influenza Viruses Isolated from Patients (2012) (15)
- Isolation of influenza A viruses from migratory waterfowls in San-in District, Western Japan in winters of 1980-1982. (1987) (15)
- Serological evidence of infection of dogs with human influenza viruses in Japan (2013) (15)
- Pathogenicity of H5N1 influenza A viruses isolated in Vietnam between late 2003 and 2005. (2006) (15)
- C57BL/6J and C57BL/6NJ Mice Are Differentially Susceptible to Inflammation-Associated Disease Caused by Influenza A Virus (2019) (15)
- The Role of EGFR in Influenza Pathogenicity: Multiple Network-Based Approaches to Identify a Key Regulator of Non-lethal Infections (2019) (15)
- Durability of immune responses to the BNT162b2 mRNA vaccine. (2022) (15)
- Filoviruses: recent advances and future challenges. (2007) (15)
- Molecular analysis of the haemagglutinin gene of an avian H1N1 influenza virus. (1990) (15)
- Development of high-yield influenza B virus vaccine viruses (2016) (15)
- Biological significance of the U residue at the -3 position of the mRNA sequences of influenza A viral segments PB1 and NA. (2004) (14)
- Region Required for Protein Expression from the Stop-Start Pentanucleotide in the M Gene of Influenza B Virus (2009) (14)
- Early Human B Cell Response to Ebola Virus in Four U.S. Survivors of Infection (2019) (14)
- Origin of the hemagglutinin on A/Equine/Johannesburg/86 (H3N8): the first known equine influenza outbreak in South Africa (2005) (14)
- Intracerebral pathogenicity for chickens of avian influenza viruses isolated from free-living waterfowl in Japan. (1988) (14)
- Characteristics of Yersinia enterocolitica bacteriophages. (1982) (14)
- Isolation of influenza A viruses from migratory waterfowls in San-in District, Western Japan, in the winter of 1982-1983. (1987) (14)
- Influenza A viruses possessing type B hemagglutinin and neuraminidase: potential as vaccine components. (2004) (14)
- Limited SARS-CoV-2 diversity within hosts and following passage in cell culture (2020) (14)
- Reverse genetics approach towards understanding pathogenesis of H5N1 Hong Kong influenza A virus infection. (2001) (14)
- The host protein CLUH participates in the subnuclear transport of influenza virus ribonucleoprotein complexes (2016) (14)
- A recombinant influenza virus vaccine expressing the F protein of respiratory syncytial virus (2014) (14)
- Stimulation of alpha2-adrenergic receptors impairs influenza virus infection (2018) (13)
- Highly susceptible SARS-CoV-2 model in CAG promoter–driven hACE2-transgenic mice (2021) (13)
- Specific COVID-19 Symptoms Correlate with High Antibody Levels against SARS-CoV-2 (2021) (13)
- A Glycolipid Adjuvant, 7DW8-5, Enhances the Protective Immune Response to the Current Split Influenza Vaccine in Mice (2019) (13)
- Efficacy of clarithromycin against H5N1 and H7N9 avian influenza a virus infection in cynomolgus monkeys. (2019) (13)
- Seroprevalence of Pandemic 2009 (H1N1) Influenza A Virus among Schoolchildren and Their Parents in Tokyo, Japan (2011) (13)
- Potent neutralization of SARS‐CoV‐2 including variants of concern by vaccines presenting the receptor‐binding domain multivalently from nanoscaffolds (2021) (13)
- Contribution of Sec61α to the life cycle of Ebola virus. (2011) (13)
- Molecular Mechanism of Externalization of Phosphatidylserine on the Surface of Ebola Virus Particles. (2019) (13)
- Unadjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected adults. (2011) (13)
- The microtubule motor protein KIF13A is involved in intracellular trafficking of the Lassa virus matrix protein Z (2013) (13)
- Programming Multifaceted Pulmonary T Cell Immunity by Combination Adjuvants (2020) (13)
- The Induction of IL-1β Secretion Through the NLRP3 Inflammasome During Ebola Virus Infection. (2018) (13)
- Antigen Signal Strength during Priming Determines Effector CD4 T Cell Function and Antigen Sensitivity during Influenza Virus Challenge (2014) (13)
- Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV-2 Omicron BA.1 in Syrian hamsters (2022) (12)
- Reassortants with equine 1 (H7N7) influenza virus hemagglutinin in an avian influenza virus genetic background are pathogenic in chickens. (1991) (12)
- Effective mosaic-based nanovaccines against avian influenza in poultry. (2019) (12)
- A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades. (2020) (12)
- Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens (2021) (12)
- Identification of Amino Acid Residues in Influenza A Virus PA-X That Contribute to Enhanced Shutoff Activity (2019) (12)
- Diversity of Influenza A(H5N1) Viruses in Infected Humans, Northern Vietnam, 2004–2010 (2018) (12)
- A Novel Vaccine Strategy to Overcome Poor Immunogenicity of Avian Influenza Vaccines through Mobilization of Memory CD4 T Cells Established by Seasonal Influenza (2019) (12)
- Characterization of the SARS-CoV-2 B.1.621 (Mu) variant (2022) (12)
- Nucleotide sequence of the avian influenza A/Mallard/NY/6750/78 virus polymerase genes. (1989) (12)
- A Defect in Influenza A Virus Particle Assembly Specific to Primary Human Macrophages (2018) (11)
- CRISPR-Cas3-based diagnostics for SARS-CoV-2 and influenza virus (2022) (11)
- Sialoglycoproteins that bind influenza A virus and resist viral neuraminidase in different animal sera. (1994) (11)
- Efficient vagina-to-lower respiratory tract immune trafficking in a murine model of influenza A virus infection. (2007) (11)
- Synthesis of influenza virus: new impetus from an old enzyme, RNA polymerase I. (2001) (11)
- Novel modulators of p53-signaling encoded by unknown genes of emerging viruses (2021) (11)
- Differences in receptor specificity between Newcastle disease viruses originating from chickens and waterfowl. (1999) (11)
- Isolation of H5 influenza viruses from whistling swans in western Japan in November 1983. (1984) (11)
- Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75 (2022) (11)
- Antibody-free digital influenza virus counting based on neuraminidase activity (2019) (11)
- Macrocyclic peptides exhibit antiviral effects against influenza virus HA and prevent pneumonia in animal models (2021) (11)
- Virological surveillance of human influenza in Indonesia, October 2008‐March 2010 (2011) (11)
- Significance of milk as a possible source of infection for human yersiniosis. I. Incidence of Yersinia organisms in raw milk in Shimane Prefecture, Japan. (1984) (10)
- Serological analysis of Ebola virus survivors and close contacts in Sierra Leone: A cross-sectional study (2019) (10)
- A possible mechanism for selection of virulent avian influenza A viruses in 14-day-old embryonated eggs. (1998) (10)
- Genetic characterization of H5N1 influenza viruses isolated from chickens in Indonesia in 2010 (2012) (10)
- Baloxavir marboxil treatment of nude mice infected with influenza A virus. (2019) (10)
- A replication-incompetent influenza virus bearing the HN glycoprotein of human parainfluenza virus as a bivalent vaccine. (2013) (10)
- Efficient Detection of BRAF Mutation in Plasma of Patients after Long- term Storage of Blood in Cell-Free DNA Blood Collection Tubes (2015) (10)
- Biochemical heterogeneity of serotype 03 strains of 700Yersinia strains isolated from humans, other mammals, flies, animal feed, and river water (1984) (10)
- Effectiveness of Whole, Inactivated, Low Pathogenicity Influenza A(H7N9) Vaccine against Antigenically Distinct, Highly Pathogenic H7N9 Virus (2018) (10)
- Serological evidence that Yersinia enterocolitica lipopolysaccharide produced during growth in vivo resembles that produced during growth in vitro at 25 degrees C. (1983) (10)
- In vitro selection of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. (2011) (10)
- A mutation in H5 haemagglutinin that conferred human receptor recognition is not maintained stably during duck passage (2010) (10)
- Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition (2021) (10)
- Significance of seasonal influenza viruses in the stool of pediatric patients. (2010) (10)
- Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters (2021) (10)
- Isolation of the antigen-active components from leptospiral serovar-specific lipopolysaccharide antigen by mild acid hydrolysis. (1982) (9)
- Potent SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models (2022) (9)
- SARS-CoV-2 Interference of Influenza Virus Replication in Syrian Hamsters (2021) (9)
- Host Factor Nucleoporin 93 Is Involved in the Nuclear Export of Influenza Virus RNA (2018) (9)
- Human protective monoclonal antibodies against the HA stem of group 2 HAs derived from an H3N2 virus-infected human. (2017) (9)
- Isolation and Characterization of Human Monoclonal Antibodies That Recognize the Influenza A(H1N1)pdm09 Virus Hemagglutinin Receptor-Binding Site and Rarely Yield Escape Mutant Viruses (2018) (9)
- Modified vaccinia virus Ankara expressing the hemagglutinin of pandemic (H1N1) 2009 virus induces cross-protective immunity against Eurasian ‘avian-like’ H1N1 swine viruses in mice (2013) (9)
- The application of advanced molecular techniques to investigate epizootics of infectious disease in the equine population. (1988) (9)
- Pathogenesis of Ebola virus infection: recent insights. (1998) (9)
- Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents (2022) (9)
- Isolation and use of eight phages for typing Yersinia enterocolitica O3. (1987) (9)
- Experimental infection of Cynomolgus Macaques with highly pathogenic H5N1 influenza virus through the aerosol route (2018) (9)
- Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron (2022) (9)
- Seasonality of influenza and other respiratory viruses (2022) (9)
- Efficacy of vaccination and previous infection against the Omicron BA.1 variant in Syrian hamsters (2022) (9)
- Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice. (2019) (9)
- Intrinsic Temperature Sensitivity of Influenza C Virus Hemagglutinin-Esterase-Fusion Protein (2013) (9)
- Effects of route and coadministration of recombinant raccoon poxviruses on immune responses and protection against highly pathogenic avian influenza in mice. (2012) (8)
- Long-term culture of human lung adenocarcinoma A549 cells enhances the replication of human influenza A viruses. (2019) (8)
- Amino acid changes in PB2 and HA affect the growth of a recombinant influenza virus expressing a fluorescent reporter protein (2016) (8)
- Triple combination therapy of favipiravir plus two monoclonal antibodies eradicates influenza virus from nude mice (2020) (8)
- Treatment of Highly Pathogenic H7N9 Virus-Infected Mice with Baloxavir Marboxil (2019) (8)
- A single-amino-acid mutation at position 225 in hemagglutinin attenuates H5N6 influenza virus in mice (2021) (8)
- Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates (2022) (8)
- H5 influenza viruses. (2006) (8)
- Intranasal administration of a live non-pathogenic avian H5N1 influenza virus from a virus library confers protective immunity against H5N1 highly pathogenic avian influenza virus infection in mice: comparison of formulations and administration routes of vaccines. (2009) (8)
- Mapping of functional domains on the influenza A virus RNA polymerase PB2 molecule using monoclonal antibodies (2014) (8)
- Ambient Temperature Stable, Scalable COVID‐19 Polymer Particle Vaccines Induce Protective Immunity (2021) (8)
- A single amino acid change in hemagglutinin reduces the cross-reactivity of antiserum against an equine influenza vaccine strain (2019) (8)
- Mutations in the Neuraminidase-Like Protein of Bat Influenza H18N11 Virus Enhance Virus Replication in Mammalian Cells, Mice, and Ferrets (2019) (8)
- Highly-Neutralizing COVID-19-Convalescent-Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters (2021) (8)
- Identification of a distinct lineage of aviadenovirus from crane feces (2019) (8)
- A Bivalent Vaccine Based on a Replication-Incompetent Influenza Virus Protects against Streptococcus pneumoniae and Influenza Virus Infection (2014) (8)
- Antigenic differences between equine influenza virus vaccine strains and Florida sublineage clade 1 strains isolated in Europe in 2019. (2021) (8)
- Identifying problematic drugs based on the characteristics of their targets (2015) (7)
- Exploring mucosal immunization with a recombinant influenza virus carrying an HIV-polyepitope in mice with pre-existing immunity to influenza. (2014) (7)
- In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6 (2022) (7)
- HER2-mediated enhancement of Ebola virus entry (2020) (7)
- The Cellular DExD/H-Box RNA Helicase UAP56 Co-localizes With the Influenza A Virus NS1 Protein (2018) (7)
- Amino acid determinants conferring stable sialidase activity at low pH for H5N1 influenza A virus neuraminidase (2012) (7)
- Soluble Recombinant Hemagglutinin Protein of H1N1pdm09 Influenza Virus Elicits Cross-Protection Against a Lethal H5N1 Challenge in Mice (2019) (7)
- Influenza Viruses: Molecular Virology (2011) (7)
- Incidence of Yersinia Organism in Hare in the Northwestern Region of Okayama Prefecture (1984) (7)
- Immunogenicity of a Recombinant Influenza Virus Bearing Both the CD4+ and CD8+ T Cell Epitopes of Ovalbumin (2011) (7)
- Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model (2022) (7)
- A protective effect of epidermal powder immunization in a mouse model of equine herpesvirus-1 infection. (2004) (7)
- Host glycolipids in SARS-CoV-2 entry (2021) (7)
- Characterization of Mouse Monoclonal Antibodies Against the HA of A(H7N9) Influenza Virus (2019) (7)
- Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza virus infection in mice (2004) (7)
- Gain-of-function experiments on H7N9. (2013) (7)
- Distinct patterns of SARS-CoV-2 transmission in two nearby communities in Wisconsin, USA (2020) (7)
- Parsing the role of NSP1 in SARS-CoV-2 infection (2022) (6)
- Lack of correlation between haemagglutination and adherence to epithelial cells in Yersinia pseudotuberculosis. (1988) (6)
- Isolation and identification of paramyxoviruses from Japanese buntings (Emberiza spodocephala) and ducks (Anas crecca and Anas penelope). (1982) (6)
- Ebolavirus’s Foibles (2017) (6)
- Villains or heroes? The raison d'être of viruses (2020) (6)
- Multi-task consensus clustering of genome-wide transcriptomes from related biological conditions (2016) (6)
- Programming Multifaceted Pulmonary T-Cell Immunity by Combination Adjuvants (2020) (6)
- Injectable Excipients as Novel Influenza Vaccine Adjuvants (2019) (6)
- M2-Deficient Single-Replication Influenza Vaccine–Induced Immune Responses Associated With Protection Against Human Challenge With Highly Drifted H3N2 Influenza Strain (2021) (6)
- Comparative Sensitivity of Rapid Antigen Tests for the Delta Variant (B.1.617.2) of SARS-CoV-2 (2021) (6)
- [The molecular basis of resistance to anti-influenza drugs]. (2006) (6)
- Isothermal Single Nucleotide Polymorphism Genotyping and Direct PCR from Whole Blood Using a Novel Whole-Blood Lysis Buffer (2009) (6)
- Sensitivity of Commercially Available Influenza Rapid Diagnostic Tests in the 2018–2019 Influenza Season (2019) (6)
- Reverse Genetics of Influenza Viruses – Applications in Research and Vaccine Design (2008) (6)
- Long-term, infection-acquired immunity against the SARS-CoV-2 Delta variant in a hamster model (2021) (6)
- Cell Host & Microbe Resource Integrated Omics Analysis of Pathogenic Host Responses during Pandemic H 1 N 1 Influenza Virus Infection : The Crucial Role of Lipid Metabolism (6)
- Development of an Influenza Rapid Diagnostic Kit Specific for the H7 Subtype (2018) (6)
- Cats as a potential source of emerging influenza virus infections (2015) (6)
- Optimization of an LNP-mRNA vaccine candidate targeting SARS-CoV-2 receptor-binding domain (2021) (6)
- A 265-Nanometer High-Power Deep-UV Light-Emitting Diode Rapidly Inactivates SARS-CoV-2 Aerosols (2022) (5)
- Dogs are highly susceptible to H 5 N 1 avian in fl uenza virus (2010) (5)
- Strain-Specific Contribution of Eukaryotic Elongation Factor 1 Gamma to the Translation of Influenza A Virus Proteins (2018) (5)
- [Classification and genome structure of influenza virus]. (2003) (5)
- Addition of new serogroups and improvement of the antigenic designs ofYersinia pseudotuberculosis (1984) (5)
- Structural Rearrangement of the Ebola Virus VP40 Protein Begets Multiple Functions in the Virus Life Cycle (2014) (5)
- A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model. (2004) (5)
- G Protein Pathway Suppressor 1 Promotes Influenza Virus Polymerase Activity by Activating the NF-κB Signaling Pathway (2019) (5)
- Pseudoparticle Neutralization Assay for Detecting Ebola- Neutralizing Antibodies in Biosafety Level 2 Settings (2015) (5)
- The nucleoprotein and matrix protein segments of H5N1 influenza viruses are responsible for dominance in embryonated eggs. (2011) (5)
- Identification of Yersinia enterocolitica O15 lipopolysaccharide as a rough antigen (1986) (5)
- Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2 (2021) (5)
- Temperature-dependent variation in the synthesis of the receptor for Yersinia enterocolitica bacteriophage XI. (1982) (5)
- Parsing the role of NSP1 in SARS-CoV-2 infection (2022) (5)
- The Cytoplasmic Tail Domain of Influenza B Virus Hemagglutinin Is Important for Its Incorporation into Virions but Is Not Essential for Virus Replication in Cell Culture in the Presence of Compensatory Mutations (2012) (5)
- Epitope mapping of the influenza A virus RNA polymerase PA using monoclonal antibodies (2014) (5)
- Acetylation of the influenza A virus polymerase subunit PA in the N‐terminal domain positively regulates its endonuclease activity (2021) (5)
- Lysogenicity and phage typing of Yersinia enterocolitica isolated in Japan. (1982) (5)
- Epitope mapping of the influenza A virus RNA polymerase PA using monoclonal antibodies (2000) (5)
- A Eurasian avian-like H1N1 swine influenza reassortant virus became pathogenic and highly transmissible due to mutations in its PA gene (2022) (4)
- Assays for functional binding of plasminogen to viral proteins. (2000) (4)
- Influenza Virus Polymerase Mutation Stabilizes a Foreign Gene Inserted into the Virus Genome by Enhancing the Transcription/Replication Efficiency of the Modified Segment (2019) (4)
- Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate (2023) (4)
- Migratory waterfowl as flying reservoirs of Yersinia species. (1984) (4)
- SARS-CoV-2 direct cardiac damage through spike-mediated cardiomyocyte fusion (2020) (4)
- A Large Extension to HIV-1 Gag, Like Pol, Has Negative Impacts on Virion Assembly (2012) (4)
- NS1 is the fluid for “flu-transmission” (2017) (4)
- Pathogenesis of influenza A(H7N9) virus in aged non-human primates. (2020) (4)
- Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual. (2022) (4)
- Pulmonary lesions induced by SARS-CoV-2 infection in domestic cats (2021) (4)
- Safety and Immunogenicity of M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR) in Adults (2021) (4)
- [Receptor specificity of influenza viruses]. (2008) (4)
- Plasticity of the Influenza Virus H5 HA Protein (2021) (4)
- Sialyl sugar chains as receptors and determinants of host range of influenza A viruses (2001) (4)
- Calculated risk: a new single-nucleotide polymorphism linked to severe influenza disease (2017) (4)
- Nasally-delivered interferon-λ protects mice against upper and lower respiratory tract infection of SARS-CoV-2 variants including Omicron (2022) (4)
- Fever, Diarrhea, and Severe Disease Correlate with High Persistent Antibody Levels against SARS-CoV-2 (2021) (4)
- [Classification and virion structure of influenza virus]. (2006) (3)
- Non-musclemyosin IIA is a functional entry receptor for herpes simplex virus-1 (2010) (3)
- Pathogenic Studies and Antigenic and Sequence Comparisons of A/Equine/Alaska/1/91 (H3NS) Influenza Virus (1993) (3)
- [Avian influenza viruses isolated in Japan]. (2005) (3)
- Rhizopus Oryzae Skin Infection Treated With Posaconazole in a Boy With Chronic Granulomatous Disease (2010) (3)
- The Low-pH Resistance of Neuraminidase Is Essential for the Replication of Influenza A Virus in Duck Intestine following Infection via the Oral Route (2016) (3)
- Isolation of an Egg-Adapted Influenza A(H3N2) Virus without Amino Acid Substitutions at the Antigenic Sites of Its Hemagglutinin. (2018) (3)
- Evaluation of seasonal influenza vaccines for H1N1pdm09 and type B viruses based on a replication-incompetent PB2-KO virus. (2017) (3)
- A Viruses Pandemic Threat Posed by Avian Influenza (2000) (3)
- Isolation of Highly Pathogenic H5N1 Influenza Viruses in 2009–2013 in Vietnam (2019) (3)
- Characterization of H7N9 avian influenza viruses isolated from duck meat products. (2020) (3)
- Structure of an Ebola Virus-Protective Antibody in Complex with its Mucin-Domain Linear Epitope. (2012) (3)
- Antigenic Change in Human Influenza A(H2N2) Viruses Detected by Using Human Plasma from Aged and Younger Adult Individuals (2019) (3)
- The HA1 of cold-adapted influenza B vaccine is not altered during replication in human vaccinees. (1995) (3)
- Improved neutralizing antibody response in the second season after a single dose of pandemic (H1N1) 2009 influenza vaccine in HIV-1-positive adults. (2012) (3)
- [Clue to the molecular mechanism of virulence of highly pathogenic H5N1 avian influenza viruses isolated in 2004]. (2005) (3)
- Antigenic variants of influenza B viruses isolated in Japan during the 2017‐2018 and 2018‐2019 influenza seasons (2020) (3)
- Structure of the Ebola Virus Nucleocapsid Core by Single Particle Cryo-Electron Microscopy (2016) (3)
- Robustness of the Ferret Model for Influenza Risk Assessment Studies: a Cross-Laboratory Exercise (2022) (3)
- Suppression of heat-stable enterotoxin production by Yersinia spp. in milk. (1986) (3)
- Russell Influenza Virus to Evolve in a Mammalian Host Transmissible A / H 5 N 1 − The Potential for Respiratory Droplet (2012) (3)
- Interferon induction by avian infectious bronchitis virus in chickens. (1982) (3)
- Host Range of Influenza A Viruses Sialic Acid Species as a Determinant of the (2000) (3)
- A Novel Method to Reduce ELISA Serial Dilution Assay Workload Applied to SARS-CoV-2 and Seasonal HCoVs (2021) (2)
- Emergence of SARS-CoV-2 and its outlook. (2020) (2)
- Generation of vero cells expressing ebola virus glycoprotein. (2009) (2)
- H6 Influenza Viruses Pose a Potential Threat to Human Health (2014) (2)
- 2748. Single Intranasal (IN) Dose of M2SR (M2-Deficient Single Replication) Live Influenza Vaccine Protects Adults Against Subsequent Challenge with a Substantially Drifted H3N2 Strain (2019) (2)
- Characteristics of influenza virus genome mutations. (2011) (2)
- Identification of Novel Adjuvants for Ebola Virus-Like Particle Vaccine (2020) (2)
- Binding properties of GP1 protein of Borna disease virus. (2009) (2)
- CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus (2021) (2)
- Infectivity for mice of avian influenza A viruses of H7N7, H5N3 and H2N2 subtypes isolated from migratory waterfowls in San-in District, Western Japan. (1987) (2)
- Potential risk of repeated nasal vaccination that induces allergic reaction with mucosal IgE and airway eosinophilic infiltration in cynomolgus macaques infected with H5N1 highly pathogenic avian influenza virus. (2017) (2)
- Neo-Virology: the raison d'etre of viruses. (2019) (2)
- Characterization of H9N2 Avian Influenza Viruses Isolated from Poultry Products in a Mouse Model (2020) (2)
- Reduced airborne transmission of SARS-CoV-2 BA.1 Omicron virus in Syrian hamsters (2022) (2)
- [Selective packaging mechanism for influenza A virus]. (2006) (2)
- Ambient Temperature Stable, Scalable COVID‐19 Polymer Particle Vaccines Induce Protective Immunity (Adv. Healthcare Mater. 3/2022) (2022) (2)
- Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike (2021) (2)
- Isolation and serotyping ofYersinia pseudotuberculosis in humans in Japan (1982) (2)
- From the Academy Emerging viral diseases (2000) (2)
- mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2 (2021) (2)
- Asymmetric and Non-Stoichiometric Recognition Results in Broad Protection Against Ebolaviruses by a Two-Antibody Cocktail (2021) (2)
- Isolation of bat sarbecoviruses of SARS-CoV-2 clade, Japan (2022) (2)
- mRNA COVID‐19 vaccine effectiveness against SARS‐CoV‐2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021 (2021) (2)
- A Lethal Outbreak Of H5N2 Influenza in Poultry in the USA: Virus Characterization and Host Range (1986) (2)
- Infl uenza A ( H 5 N 1 ) Viruses from Pigs , Indonesia (2019) (2)
- Intranasal M2SR (M2-Deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies in Adults (2022) (2)
- Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses (2022) (2)
- Growth properties and immunogenicity of a virus generated by reverse genetics for an inactivated equine influenza vaccine. (2021) (2)
- Sialylated and sulfated N-Glycans in MDCK and engineered MDCK cells for influenza virus studies (2022) (2)
- Oseltamivir Is Effective against 1918 Influenza Virus Infection of Macaques but Vulnerable to Escape (2019) (2)
- Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody to antigenically distinct omicron SARS-CoV-2 subvariants (2022) (2)
- Are twindemics occurring? (2022) (2)
- Influenza Viruses Suitable for Studies in Syrian Hamsters (2022) (2)
- Ebola Conquers West Africa — More to Come? (2014) (2)
- Repurposing Fragile X Drugs to Inhibit SARS-CoV-2 Viral Reproduction (2020) (2)
- Longevity and Mechanism of Heterosubtypic Protection Induced by M2SR (M2-Deficient Single-Replication) Live Influenza Virus Vaccine in Mice (2022) (2)
- Molecular Characterization of H5N2 Influenza Viruses from Chickens (1988) (2)
- The First Successful Isolation and Identification of Yersinia pseudotuberculosis Serogroup IIA in Japan (1982) (2)
- Neo-virology: The raison d'etre of viruses. (2019) (2)
- 9. The genome and its manipulation: Recovery of the 1918 virus and vaccine virus generation (2013) (2)
- 1970. Phase 1 Clinical Trial of Intranasal Immunization with M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR): Safety and Immune Response in Adults (2018) (1)
- Pandemic Influenza~!2010-01-17~!2010-04-05~!2010-08-27~! (2010) (1)
- Influenza Virus Transmission of the 2009 H 1 N 1 Pandemic and PB 2 Contribute to Efficient Key Molecular Factors in Hemagglutinin (2012) (1)
- Predicting host immune cell dynamics using tissue gene expression (2018) (1)
- Influenza Virus PB 2 Protein Enhances Virulence through the Disruption of Inflammatory and Wnt-Mediated Signaling in Mice (2016) (1)
- A humanized MDCK cell line for the efficient isolation and propagation of human influenza viruses (2019) (1)
- Instructions for use Title Protective Efficacy of Passive Immunization with Monoclonal Antibodies in Animal Models of H 5 N 1 HighlyPathogenic Avian Influenza Virus Infection (2018) (1)
- E-105 Antibodies against ebola virus: Results of the viral hemorrhagic fever immunotherapeutic consortium (2016) (1)
- Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020–March 2022 (2022) (1)
- Isolation of Bat Sarbecoviruses, Japan (2022) (1)
- A bivalent vaccine based on a replication-incompetent influenza virus 1 protects against Streptococcus pneumoniae and influenza virus infection 2 Running title : Bivalent vaccine for respiratory infectious disease 3 (2014) (1)
- [Genetic and molecular characteristics of the 2009 H1N1 pandemic influenza A virus]. (2010) (1)
- [The enigma of influenza virus genome packaging revealed]. (2003) (1)
- Author response for "Acetylation of the influenza A virus polymerase subunit PA in the N-terminal domain positively regulates its endonuclease activity" (2021) (1)
- Collaboration with China (2014) (1)
- [Molecular determinants associated with high virulence of influenza A virus]. (2007) (1)
- [Transmissibility and pathogenicity of influenza viruses]. (2010) (1)
- Generation of a stably attenuated influenza virus by reverse genetics (1994) (1)
- [Virological characteristics of pandemic (H1N1) 2009 influenza virus]. (2010) (1)
- Avian H7N9 influenza viruses are evolutionarily constrained by stochastic processes during replication and transmission in mammals (2022) (1)
- Food Additives as Novel Influenza Vaccine Adjuvants (2019) (1)
- World Flu Day, Be Aware of the Unavoidable Enemy — November 1, 2020 (2020) (1)
- Difference in receptor specificity among influenza A viruses from different species of animals. (1991) (1)
- Interim Estimates of 2022–23 Seasonal Influenza Vaccine Effectiveness — Wisconsin, October 2022–February 2023 (2023) (1)
- Optimization of animal models to better predict influenza vaccine efficacy (VA). (2020) (1)
- P115 Pathogenic Influenza A viruses and SARS-Coronaviruses modulate global interferon stimulated gene induction through diverse mechanisms (2012) (1)
- Transmission of Avian Influenza Viruses to Humans: Viral Receptor Specificity and Distribution in Human Airways (2008) (1)
- Proactive Engagement of the Expert Meeting in Managing the Early Phase of the COVID-19 Epidemic, Japan, February–June 2020 (2021) (1)
- Development of an mRNA vaccine against COVID-19 (2021) (1)
- CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus (2021) (1)
- [Influenza pandemic--current crisis]. (2006) (1)
- Correction: Genetics, Receptor Binding Property, and Transmissibility in Mammals of Naturally Isolated H9N2 Avian Influenza Viruses (2020) (1)
- Identification of SARS-CoV-2 Mpro inhibitors containing P1’ 4-fluorobenzothiazole moiety highly active against SARS-CoV-2 (2023) (1)
- The accuracy of reverse genetics systems for SARS‐CoV‐2: Circular polymerase extension reaction versus bacterial artificial chromosome (2023) (1)
- Influenza Epidemics and Pandemics (2010) (1)
- Difference in replication and pathogenicity of influenza A viruses in chickens and mice. (1991) (1)
- Effectiveness of HEPA Filters at Removing Infectious SARS-CoV-2 from the Air (2022) (1)
- The New Anti-influenza Drug Baloxavir Marboxil: Can Influenza Viruses with Reduced Susceptibility to Baloxavir Maintain Viral Fitness? (2020) (1)
- hemagglutinin induces heterosubtypic immunity in (2014) (1)
- [Identification of host factors involved in influenza virus replication]. (2009) (1)
- Casirivimab/imdevimab for active COVID-19 pneumonia persisted for nine months in a patient with follicular lymphoma during anti-CD20 therapy. (2022) (1)
- The evolution of mammalian and avian influenza H3 hemagglutinin genes (1988) (1)
- Evaluation of the fusion partner cell line SPYMEG for obtaining human monoclonal antibodies against influenza B virus (2018) (1)
- Molecular Mechanisms Underlying Oseltamivir Resistance Mediated by an I 117 V Substitution in the Neuraminidase of Subtype H 5 N 1 Avian In fl uenza AViruses (2012) (1)
- Antibody responses to a reverse genetics-derived bivalent inactivated equine influenza vaccine in Thoroughbred horses. (2021) (1)
- Selection of Antigenically Advanced Variants of Influenza Viruses. (2018) (1)
- Assembly of Immunogenic Protein Particles toward Advanced Synthetic Vaccines. (2022) (1)
- An efficient plasmid-driven system for the generation of influenza virus-like particles for vaccine (2001) (1)
- Reverse Genetics Approaches for Rational Design of Inactivated and Live Attenuated Influenza Vaccines (2014) (0)
- Cats as a potential source of emerging influenza virus infections (2015) (0)
- Sensitivity of Influenza Rapid Diagnostic Tests to H5N1 and 2009 Pandemic H1N1 Viruses (cid:1) (2010) (0)
- Construction and application of the recombinant influenza viruses (2009) (0)
- Oral intake of heat-killed Lactiplantibacillus pentosus ONRICb0240 partially protects mice against SARS-CoV-2 infection (2023) (0)
- Predicting Host Immune Cell Dynamics and Key Disease-Associated Genes Using Tissue Transcriptional Profiles (2019) (0)
- Importance of the length of the connecting peptide for cleavage of the influenza virus hemagglutinin (1988) (0)
- Dedication: Jim Orzechowski (1944–2003) and Michael Kiley (1942–2004) (2007) (0)
- Structural transformation begets multiple functions in the viral life cycle (2018) (0)
- Basic Research Reveals the Unique Virologic Features of SARS-CoV-2 (2021) (0)
- [Avian influenza virus]. (2005) (0)
- A recombinant influenza virus vaccine expressing the F protein of respiratory syncytial virus (2013) (0)
- Amino acids associated with intestinal replication of influenza A virus in ducks: relationship to low pH stability of neuraminidase (2004) (0)
- Highly Pathogenic H5 Influenza Viruses Isolated between 2016 and 2017 in Vietnamese Live Bird Markets (2023) (0)
- COVID-19 Infection Induces Substantial Memory B Cell Maturation to Non-Neutralizing Viral Targets (2021) (0)
- Therapeutic effects of angiotensin converting enzyme 2 (ACE2) enzyme activity on acute lung injury in COVID-19 (2022) (0)
- Ebola virus nucleoprotein-RNA complex (2018) (0)
- Influenza virus (VN1194) H5 HA (2006) (0)
- H3N2 Influenza Viruses with 12- or 16-Amino Acid Deletions in the Receptor-Binding Region of Their Hemagglutinin Protein (2021) (0)
- Mucosal and Systemic Immune Responses to a Human Immunodeficiency Virus Type 1 Epitope Induced upon Vaginal Infection with a Recombinant Influenza A Virus (2003) (0)
- HOST RANGE OF INFLUENZA VIRUSES AND APPROACH TO DEVELOP NEW ANTI-INFLUENZA DRUGS (2002) (0)
- Multi-omics of NET formation and correlations with CNDP1, PSPB, and L-cystine levels in severe and mild COVID-19 infections (2023) (0)
- The D3-9 gene segment encodes for recurring and adaptable binding motifs in broadly neutralizing antibodies to influenza virus (2018) (0)
- Antigenicity oftheN8Influenza A Virus Neuraminidase: Existence ofanEpitope attheSubunit Interface oftheNeuraminidase (1994) (0)
- Control of Ebola hemorrhagic fever: vaccine development and our Ebola project in Sierra Leone. (2016) (0)
- Protective efficacy of a reverse genetics-derived inactivated vaccine against equine influenza virus in horses. (2022) (0)
- Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1 (2023) (0)
- Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization (2021) (0)
- Influenza Pandemics and Control (2008) (0)
- Coronavirus Immunotherapeutic Consortium Database (2023) (0)
- Receptor-Binding Specificity of Influenza Viruses. (2022) (0)
- Genetic characterization of H5N1 influenza viruses isolated from chickens in Indonesia in 2010 (2012) (0)
- Acetylation on NP of influenza virus by histone acetyltransferases in host cells affects viral transcription activities (2016) (0)
- Recombinant influenza virus for vaccine production and gene therapy (2000) (0)
- Replicative capacity of SARS-CoV-2 omicron variants BA.5 and BQ.1.1 at elevated temperatures (2023) (0)
- Forthcoming paper (1996) (0)
- Title Importance of the 1 + 7 configuration of ribonucleoproteincomplexes for influenza A virus genome packaging (2018) (0)
- The Cellular Factors Vps18 and Mon2 Are Required for Efficient Production of Infectious HIV-1 Particles (cid:1) (2011) (0)
- (54) HIGH TITER RECOMBINANT INFLUENZA VIRUSES FOR VACCINES AND GENE THERAPY (2013) (0)
- Characterizing Emerging Canine H3 Influenza Viruses. (2020) (0)
- Which Virus Will Cause the Next Pandemic? (2023) (0)
- Lack of correlation between haemagglutination and adherence to epithelial cells in Yersinia pseudo tuberculosis (0)
- Stimulation of alpha2-adrenergic receptors impairs influenza virus infection (2018) (0)
- [Anti-influenza drug--current status and future prospects]. (2012) (0)
- ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury (2021) (0)
- 1. SARS-CoV-2: What We Learned So Far (2021) (0)
- (54) RECOMBINANT INFLUENZA VECTORS WITH A POLII PROMOTER AND RIBOZYMES FOR VACCINES AND GENE THERAPY (2010) (0)
- Attenuation of an influenza A virus due to alteration of its hemagglutinin-neuraminidase functional balance in mice (2012) (0)
- substitution in the NA of H5N1 avian influenza viruses (2012) (0)
- Evolution oftheH3Influenza VirusHemagglutinin from HumanandNonhumanHosts (1992) (0)
- Mutations in influenza A virus during amantadine-oseltamivir combination therapy (2010) (0)
- CTen: a web-based platform for identifying enriched cell types from heterogeneous microarray data (2012) (0)
- Previous omicron infection may be protective against reinfection with omicron variant BA.5 for at least 5 months (2022) (0)
- Generation of Transgenic Mosquitoes Harboring a Replication-Restricted Virus (2022) (0)
- The potential of influenza viruses from natural reservoirs for virulence (1988) (0)
- Programming effective respiratory immunity to influenza with combination microparticle adjuvants (2020) (0)
- Instructions for use Title Influenza A Virus Can Undergo Multiple Cycles of Replicationwithout M 2 Ion Channel Activity (2017) (0)
- [Dynamics of influenza virus pathogenicity]. (1995) (0)
- influenza A virus. ribonucleoprotein complex and origin of human implications for evolution of the Evolution of influenza A virus PB2 genes (2013) (0)
- Establishment of human airway epithelial cells with doxycycline-inducible cell growth and fluorescence reporters (2021) (0)
- A broadly protective human monoclonal antibody targeting the sialidase activity of influenza A and B virus neuraminidases (2022) (0)
- Virus Challenge and Antigen Sensitivity during Influenza Determines Effector CD4 T Cell Function Antigen Signal Strength during Priming (2014) (0)
- Vecteurs recombinants de la grippe avec des unites de transcription en tandem (2005) (0)
- Molecular Aspects of Emerging Negative Strand RNA Viruses (2003) (0)
- The Molecular Tool‐Kit of Viral Hemorrhagic Fevers (2015) (0)
- Crystal Structure of H5 (tyTy) Influenza Virus Haemagglutinin (2013) (0)
- Editorial Board (2016) (0)
- Novel Approach to the Development of Effective H5N1 Influenza A Virus Vaccines: Use of M2 Cytoplasmic Tail Mutants (cid:1) (2008) (0)
- Host network-based discovery of critical regulators of innate immunity, virus growth, and pathogenesis in influenza virus infection (2022) (0)
- Triple combination therapy of favipiravir plus two monoclonal antibodies eradicates influenza virus from nude mice (2020) (0)
- InfectionsConcurrent Mycobacterial and Influenza Interactions between T Cells Responding to (2006) (0)
- Genetic approach to studying influenza pathogenesis (2001) (0)
- Filovirus Assembly and Budding (2008) (0)
- Author Correction: Cryo-EM structure of the Ebola virus nucleoprotein–RNA complex at 3.6 Å resolution (2022) (0)
- Uncovering the Anti-Ebola Repertome. (2020) (0)
- Experimental infection of Cynomolgus Macaques with highly pathogenic H5N1 influenza virus through the aerosol route (2018) (0)
- Ferret model to mimic the sequential exposure of humans to historical H3N2 influenza viruses. (2022) (0)
- Virus epidemic: Influenza and foot-and-mouth disease (IS) Chairpersons: Rafi Ahmed, Wayne R. Hein (2010) (0)
- Influenza A variants with reduced susceptibility to baloxavir isolated from Japanese patients are fit and transmit through respiratory droplets (2019) (0)
- Avian Influenza Viruses (2012) (0)
- [The packaging of influenza viral genome]. (2002) (0)
- Haemagglutinin from a Transmissible Mutant H5 Influenza Virus in Complex with Avian Receptor Analogue 3'-SLN (2013) (0)
- A Critical Domain of Ebolavirus Envelope Glycoprotein Determines Glycoform and Infectivity (2018) (0)
- Marburg and Ebola Viruses – Marking 50 Years Since Their Discovery (2018) (0)
- Medicament for the treatment of influenza (2008) (0)
- Multicolor two-photon imaging of in vivo cellular pathophysiology upon influenza virus infection using the two-photon IMPRESS (2020) (0)
- Pathogenic H1N1 2009 influenza virus-induced pulmonary injury is suppressed by sphingosine analog-mediated inhibition of cytokine storm (49.3) (2011) (0)
- Signal for packaging vectors of influenza virus (2003) (0)
- Host protein mimics viral protein to hinder infection by Ebola virus (2019) (0)
- SARS-CoV-2 Transmission from Virus-Infected Dead Hamsters (2023) (0)
- Isothermal single nucleotide polymorphism genotyping and direct PCR from whole blood using a novel whole-blood lysis buffer. (2009) (0)
- Options for the control of influenza (2002) (0)
- Mediator complex subunit 12 is a gatekeeper of SARS-CoV-2 infection in breast cancer cells (2021) (0)
- An open letter to the NSABB re the political and ethical implications of lethal virus development (2012) (0)
- Protective human MAbs to a highly conserved conformational determinant on influenza M2e (38.14) (2010) (0)
- Establishment of SARS-CoV-2 respiratory tract infection model in CAG promoter-driven hACE2 transgenic mice (2022) (0)
- A Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice From Secondary Pneumococcal Pneumonia. (2015) (0)
- Effectiveness of first and second COVID‐19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021–July 2022 (2023) (0)
- I. Animal Models of SARS-CoV-2 Infection and Pathogenesis (2020) (0)
- Diversity of antigenic mutants of influenza A(H1N1)pdm09 virus escaped from human monoclonal antibodies (2017) (0)
- Ebolaviruses: What We Know and Where We Are on Potential Therapeutics (2011) (0)
- Cryo-EM structure of the Ebola virus nucleoprotein–RNA complex at 3.6 Å resolution (2018) (0)
- Biologic Importance ofNeuraminidase Stalk Lengthin Influenza A Virus (1993) (0)
- TREATMENT WITH A SPHINGOSINE ANALOG DIMINSHES IMMUNOPATHOLOGY FOLLOWING INFLUENZA VIRUS INFECTION (45.2) (2009) (0)
- Virus influenza de recombinaison a titre eleve pour vaccins et therapie genique (2004) (0)
- Interaction between Filovirus Proteins and Host Cell Membrane (2005) (0)
- Fc-modified SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models (2022) (0)
- [Genetic manipulation of influenza A viruses]. (2000) (0)
- Chimeric hPIV2/Corona-Spike Nasal Vaccine Robustly Protects the Upper and Lower Airways Against SARS-CoV-2 (2021) (0)
- Quadrivalent Formulation of Intranasal Influenza Vaccine M2SR (M2-Deficient Single Replication) Protects against Drifted Influenza A and B Virus Challenge (2023) (0)
- Crystal structure of Marburg virus VP35 RNA binding domain (2012) (0)
- Crystal structure of Marburg virus VP35 RNA binding domain bound to 12-bp dsRNA (2012) (0)
- in dogs.systematic study of Yersinia spp. (2013) (0)
- Crystal Structure of the Haemagglutinin from a Transmissible Mutant H5 Influenza Virus (2013) (0)
- Importance of the 1+7 configuration of ribonucleoprotein complexes for influenza A virus genome packaging (2018) (0)
- Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences: 356 (1416) (2001) (0)
- Correction: A Large Extension to HIV-1 Gag, Like Pol, Has Negative Impacts on Virion Assembly (2015) (0)
- Abstract 2560: Narrow Bottlenecks Constrain Influenza A Virus Genetic Diversity During Direct Contact Transmission (2023) (0)
- Plasminogen activator inhibitor 1 is not a major causative factor for exacerbation in a mouse model of SARS-CoV-2 infection (2023) (0)
- Host protein mimics viral protein to hinder infection by Ebola virus (2019) (0)
- Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants (2023) (0)
- Current and future influenza vaccines (2019) (0)
- Immunogenicity and Protective Efficacy of Replication-Incompetent Influenza Virus-Like Particles (2001) (0)
- S15.3 Sialyl sugar chain-method recognition of influenza viruses (1993) (0)
- Sialylated and sulfated N-Glycans in MDCK and engineered MDCK cells for influenza virus studies (2022) (0)
- TheHemagglutinins ofDuckandHumanHiInfluenza Viruses Differ inSequence Conservation andinGlycosylation (1993) (0)
- Reactivity and sensitivity of commercially available influenza rapid diagnostic tests in Japan (2017) (0)
- [Mechanisms of influenza virus replication]. (2010) (0)
- Supplemental Information Selective Bottlenecks Shape Evolutionary Pathways Taken during Mammalian Adaptation of a 1918-like Avian In fl uenza Virus (0)
- Involvement in Virus Adaptation in a New Host Human Influenza H 3 N 2 Virus and Their Molecular Mechanisms of Serum Resistance of (1998) (0)
- High titers of infectious SARS-CoV-2 in corpses of patients with COVID-19 (2023) (0)
- Genetic incompatibility among influenza A viruses (2001) (0)
- Antibody-free digital influenza virus counting based on neuraminidase activity (2019) (0)
- , H 7 N 9 and Seasonal Influenza Viruses Replication of Emerging In Vivo Role in The Host Protease TMPRSS 2 Plays a Major (2014) (0)
- Addressing the Threat of Emerging Viral Infections. (2023) (0)
- Comparison of the Pathogenicity in Mice of A(H1N1)pdm09 Viruses Isolated between 2009 and 2015 in Japan (2020) (0)
- The COVID-19 Pandemic—A Potential Role for Antivirals in Mitigating Pandemics (2023) (0)
- Can SARS-CoV-2 transmit from a dead body? (2022) (0)
- Instructions for use Title Infectivity-Enhancing Antibodies to Ebola Virus Glycoprotein (2017) (0)
- Glycosylation and an amino acid insertion in the head of hemagglutinin independently affect the antigenic properties of H5N1 avian influenza viruses (2018) (0)
- Identification of interferon-stimulated genes that attenuate Ebola virus infection (2020) (0)
- Role of plasminogen-binding neuraminidase in influenza pathogenicity (2001) (0)
- Medicament destine au traitement de la grippe (2008) (0)
- United States Patent (2011) (0)
- In SARS-CoV-2 delta variants, Spike-P681R and D950N promote membrane fusion, Spike-P681R enhances spike cleavage, but neither substitution affects pathogenicity in hamsters (2023) (0)
- Subject Index, Vol. 35, 1993 (1993) (0)
- Molecular changes in H5N2 avian influenza virus associated with the acquisition of virulence (1985) (0)
- Omicron proliferation in the nasal cavity may explain its high infectivity (2023) (0)
- [Cutting-edge of medicine; pandemic potential of H5N1 influenza virus]. (2013) (0)
- High titers of infectious SARS-CoV-2 in COVID-19 corpses (2022) (0)
- Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19 mouse model (2021) (0)
- In vivo Imaging of the Cellular Pathophysiology in Influenza Virus-infected Mouse Lung (2021) (0)
- Immunological correlates of prevention of the onset of seasonal H3N2 influenza. (2022) (0)
- Crystal Structure of H5 (VN1194) Influenza Haemagglutinin (2013) (0)
- Potential for use of influenza A viruses with chimeric (type A/B) hemagglutinins as vaccines (2004) (0)
- Acetylation on NP of influenza virus by histone acetyltransferases in host cells affects viral RNA polymerase activities (2017) (0)
- Filoviruses: closing the gap on a killer: Marburg and Ebola Viruses (Current Topics in Microbiology and Immunology series) edited by H-D. Klenk (1999) (0)
- Identification of Amino Acid Changes That May Have Been Critical for the Genesis of A(H7N9) Influenza Viruses (2014) (0)
- A RADIOIMMUNOASSAY SYSTEM USING A SEROVAR-SPECIFIC LIPOPOLYSACCHARIDE ANTIGEN OF LEPTOSPIRA, AND STUDIES ON THE CHEMICAL NATURE OF THE ANTIGENIC SITES (1980) (0)
- Instructions for use Title Hierarchy among viral RNA ( vRNA ) segments in their role invRNA incorporation into influenza A virions (2017) (0)
- Reviewer Acknowledgment (2003) (0)
- Recent Findings on H1N1 (2009) (0)
- Antigenic drift originating from changes to the lateral surface of the neuraminidase head of influenza A virus (2019) (0)
- [Round table discussion on highly pathogenic H5N1 avian influenza]. (2004) (0)
- Subclade 2.2.1-Specific Human Monoclonal Antibodies That Recognize an Epitope in Antigenic Site A of Influenza A(H5) Virus HA Detected between 2015 and 2018 (2019) (0)
- Rekombinante influenzaviren mit hohem titer und erhöhter replikation in vero-zellen (2010) (0)
- Preface (2004) (0)
- Vecteurs de la grippe recombines contenant un promoteur pol ii et des ribozymes (2004) (0)
- Virus de la grippe recombinants à haut titre pour vaccins (2007) (0)
- Vecteurs d'adénovirus pour la production de virus de la grippe (2008) (0)
- Virus contenant une proteine mutante de canal ionique (2001) (0)
- Procédé de criblage destiné à la détermination de modulateurs de la transcription ou de la réplication virale (2007) (0)
- VIRUS MUTANTS DE PROTÉINE M2 DE LA GRIPPE COMME VACCINS VIVANTS ATTÉNUÉS CONTRE LA GRIPPE (2008) (0)
- Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in Japan (2022) (0)
- Characterization of Influenza A(H1N1)pdm09 Viruses Isolated in the 2018–2019 and 2019–2020 Influenza Seasons in Japan (2023) (0)
This paper list is powered by the following services:
Other Resources About Yoshihiro Kawaoka
What Schools Are Affiliated With Yoshihiro Kawaoka?
Yoshihiro Kawaoka is affiliated with the following schools:
